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ABSTRACT
Influenza A virus infections are a major cause of morbidity and mortality in the
United States and throughout the world. The current vaccine elicits primarily a humoral
response that is specific for the external glycoproteins hemagglutinin (HA) and
neuraminidase (NA). However, these are the viral proteins that are most susceptible to
antigenic shift and drift, and can evade the humoral response. Cytotoxic T lymphocytes
(CTL) recognize and lyse virus-infected cells and are important in clearing influenza A
virus infections. CTL can recognize epitopes on both the external glycoproteins and the
more conserved internal viral proteins. This thesis investigates the hypothesis that there
is a broad CTL memory response in humans
, and, if boosted by vaccines
, these CTL may
help clear influenza A virus strains of different subtypes.
The CTL repertoire specific for influenza A viruses reported in inbred mice is
extremely limited and has focused on a few immunodominant epitopes. We performed
preliminar bulk culture chromium release assays using human peripheral blood
mononuclear cells (PBMC) stimulated with influenza virus strain 
A/R/8/34 (HIN1) 
vitro. CTL activity was observed against autologous B-Iymphoblastoid cell lines (B-
LCL) infected with vaccinia constructs that expressed several influenza A viral proteins
including nucleoprotein (NP), matrix (M 1), nonstructual 
1 (NS 1) and polymerase (PB 1).
This was more diverse than the limited response reported in inbred mice. To further
characterize the CTL repertoire in humans
, PBMC from healthy adult donors were
stimulated and CTL were cloned by limiting dilution. Isolated cell lines were 
fuher
characterized by their CD4/CD8 surface expression, histocompatibility leukocyte antigen
(HLA) restriction, cross-reactive or subtype-specific influenza A subtype recognition
and epitope recognition.
CTL lines isolated from three donors recognized epitopes on many different
influenza virus proteins. The ELISPOT assay was used to identify the number of IFN-
secreting cells and determine the precursor frequency of the CTL specific for the epitopes
that were mapped. The precursor frequency ofIFN-y producing CTL ranged from 1 in
156 PBMC to 1 in 31 250 PBMC. The precursor frequency for one epitope was below
the level of detection of this assay, but most of the memory CTL were readily detected.
The cross-reactive or subtype-specific recognition of varous human influenza A subtypes
by these T cell lines was determined by chromium release assays. Most of the CTL lines
recognized B-LCL infected with any of the three influenza A subtypes that have caused
epidemics in the last centur (HIN1 , H2N2 , and H3N2) and recognized epitopes on
conserved internal influenza viral proteins. Most of the subtype-specific cell lines
recognized the surface HA or NA glycoproteins , which are not well conserved between
influenza subtypes.
Although most of the T cell lines that were characterized were cross-reactive with
influenza viruses of human origin, infection of humans with a divergent swine or avian
derived strain could cause a global pandemic. To study the human CTL responses to
non-human infuenza viruses , B-LCL were infected with an HswlNI infuenza A virus of
swine origin, and cell lines were tested for recognition of these targets in a chromium
release assay. Most cell lines lysed the targets infected with the HswlNI subtype to the
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same degree as targets infected with the human HINI strain. Two influenza viruses of
duck origin were also tested and were recognized by many of the cell lines. The subtypes
of these duck strains were HavlNI and H5N2. The isolates of influenza A virus from the
Hong Kong outbreak of 1997 were also used to infect targets and analyze recognition by
these CTL. We found that approximately 50% of the human T cell lines tested
recognized both ofthe Hong Kong isolates, 25% recognized at least one isolate , and 25%
recognized neither isolate to the same degree as the AlR/8/34 (HIN1) virus. We
analyzed the amino acid (aa) changes in the epitopes of the T cells lines from the 25% of
cell lines that did not recognize either Hong Kong virus isolate. Non-conservative
mutations were found in all ofthe epitopes that lost recognition by the human CTL lines.
Bulk cultures ofPBMC from three donors that were stimulated with AlPR/8/34 (HIN1)
influenza A virus of human origin recognized all of the non-human virus strains tested.
Thus , humans have memory CTL that recognize influenza viruses of avian and swine
species. This may provide a second line of defense against influenza infection in case of
exposure to a novel influenza A virus derived from these species.
These results made it clear that humans have broad CTL memory to influenza A
VIruS. In order to determine whether these T cells could be boosted in a vaccine
immune-stimulatory complexes (Iscom) incorporating inactivated influenza particles
were tested in vitro. Iscoms containing inactivated influenza A vaccine (Flu-Iscom) were
usedto pulse autologous B-LCL overnight that were then used as targets in chromium
release assays with human CTL lines as effectors. A CD8+ HA';specific CTL line lysed
these targets , but not targets pulsed with Iscoms alone or with inactivated influenza A
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vaccine alone. An NS I-specific cell line recognized targets pulsed with NS 1 protein and
Iscoms , but not targets pulsed with Iscoms or NS 1 protein alone. Therefore , CTL could
recognize in vitro target cells that were exposed to the Iscom vaccines containing their
specific epitope.
Flu-Iscom and Iscom mixed with inactivated influenza virus paricles (Flu-
Iscomatrix) were then used as vaccines in a clinical trial to test CTL and neutralizing
antibody induction against influenza. Fifty-five donors were bled pre-vaccination, and on
days 14 and day 56 post-vaccination. Bulk culture chromium release assays were
performed using targets infected with live vaccine strain viruses. There were
significantly more increases in the influenza A specific CTL activity in the PBMC of
donors that were vaccinated with the Flu-Iscom and Flu-Iscomatrix vaccines than in
recipients of the standard vaccine. In order to determine whether these increases in
cytotoxicity were due to an increase in the precursor frequency of influenza specific CTL
the PBMC were used in ELISPOT assays to assess the changes pre-and post-vaccination.
When there was an increase in the level of cytotoxicity detected in bulk culture CTL
there was often also an increase in the precursor frequency of influenza-specific CTL.
Peptide-specific increases in the number ofCTL that recognize epitopes such as Ml aa
58-66 were detected in several donors confirming the increase in influenza-specific CTL
post-vaccination.
Another type of T cell that may be involved in defense against viruses is the y8 T
cell. T cells expressing the y8 T cell receptor (TCR) have been found extensively in
mucosal tissues in mice and humans. Infuenza A viruses enter via the airway tract
infecting the epithelial cells at the mucosal surface. These epithelial cells have been
shown in vitro to be targets for influenza-specific cytolytic recognition of ap T cells. 
analyze whether y'6 T cells can respond to influenza A- infected APCs , PBMC were
stimulated with influenza A virus. Intracellular IFN-y staining was used to determine
whether y/'6 T cells can secrete IFN-y in response to the influenza A virus infection. We
observed an increase in the percentage ofy/'6 T cells secreting IFN- y post-influenza A
virus infection of PBMC compared to uninfected or allantoic fluid-stimulated cultures.
These T cells also upregulated CD25 and CD69 in response to live influenza A virus.
We focused on the responses in the CD8- population ofy'6 T cells , which are the majority
ofy'6 T lymphocytes. Furthermore , the increases in IFN-y production and activation
marker expression were much more clear in the CD8- y'6+ T cells. The level of CD8- y'6
T cell activation with inactivated influenza A virus was much less , and in some cases no
higher than uninfected PBMC. The CD8+ ap and y'6 responses could be partially
blocked by anti-class I antibodies, but the CD8- y'6 responses could not. Vaccinia virus
infection did not activate the CD8- y'6 T cells to the same degree as influenza virus
infection. y'6 T cells are thought to have a regulatory role that includes the secretion of
cytokines and epithelial growth factors to help restore tissue back to health.
Humans have broad multi-specific T lymphocyte responses by ap T cells to
infuenza A viruses and those responses are cross-reactive with human, avian, and swine
virus strains. These CTL can be activated in vitro and boosted in number in vivo 
Iscom incorporating vaccines. There is also a population of y'6+ T lymphocytes in
humans that responds to influenza virus infection by producing cytokines and becoming
activated. Increasing memory CTL as a second line of defense against influenza 
viruses may be important in future vaccine development.
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CHAPTER 
INTRODUCTION
A. BACKGROUND
Influenza A virus infections cause morbidity and mortality on an anual basis (Stuar-
Haris and Schild, 1976; Langmuir and Schoenbaum, 1977). This excess mortality is
usually observed in the elderly and in individuals with chronic ilness. Older children
and adults have generally had previous infections with influenza A viruses, but mutations
accrue at the major antibody combining sites allowing reinfections to occur (Webster et
aI. , 1992). Therefore , even in the healthy adult population, influenza is a major cause of
morbidity.
1. The Nature of Influenza A Viruses.
Influenza is a negative sense , single-stranded, segmented RNA virus from the
Orthomyxoviridae family. There are three types of influenza in the Orthomyxo family,
designated type A,- B , and C. Only types A and B have caused serious disease in humans;
and type A has caused the most epidemics due to its amino acid sequence variability.
Infuenza A virus has eight RNA strands that encode ten proteins including an RNA
polymerase. The error prone RNA polymerase-dependent replication creates point
mutations that can cause antigenic drift on the external glycoproteins, hemagglutinin
(HA) and neuraminidase (NA) (Laver et aI. , 1979; Moss et aI. , 1980). Changes in these
surace glycoproteins leads to virus escape from the humoral response, variation in host
species range , and changes in disease severity.
In addition, periodically a drastic antigenic change occurs in which a reassortment
of genes from one virus subtype with the genes from another virus subtype occurs, and
can result in antigenic shift. Antigenic shift may be dangerous if the new genes come
from a subtype to which humans have not been previously exposed (Webster and Laver
1975). Influenza subtypes are classified into different categories based on the antigenic
differences between the viral proteins. The nomenclature of subtypes is indicated by the
hemagglutinin (HA) and neuraminidase (NA) in parenthesis. Thus far, 15 different HA
and 9 different NA antigens have been identified (Table 1- 1). Within each subtype of
influenza virus are numerous viral strains; indicated by the influenza type A or B
location of isolation, strain number, and year of isolation, for example , AlPuerto
Rico/8/34.
2. The Epidemiology of Influenza A Viruses.
The aquatic bird reservoir is the primar source of infuenza A virus strains because all of
the infuenza subtypes have been isolated from these animals (Table 1-1) (Webster et aI.
1992). Several influenza epidemics in modern times were caused by viruses that
underwent antigenic shift, picking up genes from avian viruses (Table 1-2). For example
the 1957 "Asian Flu" was caused by a H2N2 subtype infuenza A virus that acquired
three genes (PB 1 , HA, and NA) from avian viruses. Another example is the 1968 "Hong
Kong Flu" which was caused by a H3N2 subtype of influenza A virus that acquired two
avian genes (PB 1 and HA) (Murphy and Webster, 1996).
The origin of influenza A virus pandemics is a matter of intense debate. Since the
mid-eighteen-hundreds most pandemics have appeared to originate in southern China.
Inter-species transmission is possible there due to the close living conditions between
individuals and their pigs/ducks (Webster et aI. , 1992). The H3 , H4 , and H6 subtypes of
influenza A viruses have been isolated from the domestic avian population in southern
China (Shortridge, 1982), and recently the H5 subtype was transmitted from domestic
chicken to humans in Hong Kong (Subbarao et aI. , 1998). The 1918 pandemic may be
unique in origin, possibly staring in the U.S. and being spread to Europe by U.S. troops
(Crosby, 1989), but it is also possible that the 1918 pandemic originated in Europe.
Table 1- 1. Subtypes of Influenza A Viruses Isolated from Various
. a,pecles .
Species of Origin
Subtypes Humans Swine Horses Birds
Hemagglutinin
PR/8/34 Sw/Ia/15/30 DkiAlb/35/76
(RO, HI, Hswl)
Japan/305/57 DkiGer/12I5/73
Hong Kong/I/68 Sw/Taiwan/70 Eq/Miami/1/63 Dk/kr/1/63
(Hav7 Heq2)
DklCz/56
HK156/97 TernS.A./61
Ty/Mass/3740/65
Eq/Prague/1 /5 6 FPV /Dutch/27
Ty/Ont/6I18/68
Ty/Wis/I/66
HIO CkiGer/N/49
Hll Dk/ng/56
HI2 DkiAlb/60/76
H13 Gull/MD/704/77
HI4 DkiGurjev/263/82
HI5 Dki Aust/341/83
Neuraminidase
PR/8/34 Sw/Ia/15/30 CkiScot/59
Japan/305/57 Sw/Taiwan/70 Ty/Mass/3740/65
Tem/S.A./6I
Ty/Ont/6I18/68
Sh/ Austral/l/72
DklCz/56
Eq/Prague/1/56 FPV /Dutch/2 7
Eq/Miami/1/63 Dk/kr/1/63
Dk/em/546/7 4
The table was updated from (Murhy and Webster, 1996). A dash mdicates that
no strains have been isolated from. that species.
3. Pandemics of the Century.
The influenza A pandemic of 1918- 1920 was the most severe in modern times with over
20,000 000 deaths (Collins , 1957). Most mortality occurred in young adults , unlike most
influenza epidemics which cause mortality in the elderly and young children (Collins
1957). There were no major influenza pandemics in the two decades prior to 1918
suggesting that a lack of immune memory may have contributed to the significant
mortality among the young adults. The hemagglutinin of the virus which caused the 1918
pandemic has recently been partially sequenced from autopsy tissue and has swine-like
HINI sequences (Taubenberger et aI. , 1997; Reid et aI. , 1999). Serologic studies of
individuals who were alive during that pandemic also strongly suggest that the virus had
a swine-like hemagglutinin antigen (Masurel and Marne, 1973).
It is not known why the 1918 influenza A virus caused such a high mortality rate.
Several groups speculate that acceleration of HA cleavage by a number of possible
mechanisms may have allowed the virus to spread systemically (Goto and Kawaoka
1998). Influenza is usually limited to the respiratory tract because local trypsin-like
enzmes , found only in the lung and tracheal tissue, can cleave the HA into two subunits
to allow for the infection of the virus (Steinhauer, 1999). A more virulent influenza A
virus has been hypothesized to use a more ubiquitous subtilisin-like protease , such as
fuin or PC6 , to accelerate cleavage, while avirulent viruses utilize enzymes only found
in the respiratory tract (Steinhauer, 1999). One way that other influenza A viruses have
been able to use these more ubiquitous enzymes is if the virus has many basic amino
acids at the cleavage site. It has been shown that influenza viruses with between 3 and 
basic aa at the cleavage site can be cleaved by these subtilisin-like proteases and be more
virulent (Kawaoka and Webster, 1988; Barr, 1991; Vey et aI. , 1992; Horimoto and
Kawaoka, 1994). Interestingly, the 1918 strain HA sequence does not have the numerous
basic aa at the cleavage site (Reid et aI. , 1999), and there is no evidence that the virus was
spread systemically so the mystery of its virulence remains.
Other major influenza A virus pandemics in the last century include the H2N2
subtype 1957 "Asian" flu. This subtype only circulated for approximately 10 years. The
H2N2 subtype may have been crowded out by the 1968 H3N2 subtype (Hong Kong)
which rapidly caused a pandemic and has remained to circulate in the population with
antigenic drift and to reinfect humans for over three decades. There was evidence that
the immunity from the 1957 H2N2 virus provided some protection from the 1968 H3N2
strain, since areas hit heavily by the H2N2 virus suffered far less when the H3N2 virus
arved (Gil et aI. , 1971). The mortality during each ofthese pandemics occurred
primarily in the elderly and small children, unlike the 1918 pandemic.
Table 1-2. Influenza A Virus Epidemics or Pandemics Occurring in
Humans in the Last Century
Year Virus Excess Mortality Caused by Avian or Swine
Su btype Influenza A Viruses in U. Derived Genes
1918 HswlNI 500 000 All 10 genes?
(Avian/Swine)
1957 H2N2 000 , NA , PB 1
(Avian)
1968 H3N2 000 , PB 1
(Avian)
Similar to HINI
strains of 1950s
The sources: (Langmuir and Schoenbaum, 1977) and (Murphy and Webster, 1996).
1977 HINI 000
4. Influenza A Virus Structure, Composition, and Pathogenesis.
Influenza A virus particles have been visualized by electron microscope as 120 nm in
diameter with irregular sphere shapes that have spikes protruding from the surface (HA
NA) (Choppin et aI. , 1960). Immunogold electron microscopy has proven that the M2
protein is associated with the surface of the virus (Jackson et aI. , 1991). The eight RNA
segments inside the virus exist as a ribonucleoprotein associated with nucleoprotein (NP)
and the three polymerase proteins (PB 1 , PB2 , and P A) in a helical structure. The
terminal ends of each segment create a panandle structure that is involved in the
replication process.
The HA viral protein is found on the surface of the viral paricle, and accounts for
up to 25% ofthe total viral protein (Murti and Webster, 1986). This protein is important
in attachment to sialyloglycolipids/sialyloglycoproteins and penetration into the cell. The
RNA segment encoding HA is translated as a single polypeptide chain.
Posttranslationally the molecule has an N-terminal signal sequence cleaved off, and then
the polypeptide is cleaved again removing several intervening residues to create the HAl
and HA2 molecules which are linked by a disulfide bond (Murphy and Webster, 1990).
This HA cleavage into the HAl and HA2 subunits allows the virus to be infectious. At
the N-terminus of the HA2 molecule there is a fusion peptide, very conserved between
subtypes , which undergoes a conformational change (pH = 5) to allow fusion of the viral
envelope to the endosome and release the virus paricles into the cytoplasm (Murhy and
Webster, 1990). Homology between different HA subtypes is variable , the two most
homologous subtypes are the H2 and H5 (80% homology), and the two most divergent
are the HI and H3 subtypes (25% homology)(Air, 1981). Certain cysteine residues and
other amino acids are conserved between all of the HA subtypes (Air, 1981). Thethree-
dimensional structure of the H3 molecule has been determined using X-ray
crystallography (Wilson et aI. , 1981; Wiley and Skehel , 1987). The HA protein is a
trimer composed of two regions, a triple-stranded coiled-coil of alpha-helices and a
globular region composed of antiparallel beta-sheets (Wilson et aI. , 1981; Wiley and
Skehel , 1987). The globular region contains the receptor binding site in a conserved
canyon inaccessible to antibody, the surface area outside of this canyon is where the
antigenic variability in each HA subtype occurs (Wiley and Skehel, 1987). 
The other surface glycoprotein involved in subtype characterization is the NA
viral protein. NA is a mushroom shaped spike with a square head created by four
subunits with a stalk that attaches it to the membrane (Laver and Valentine , 1969;
Wrigley, 1979). NA removes sialic acid from glycoproteins and has been shown to be
involved in the release of the virus particles from inside of the cell , and the spread of
virus from cell to cell (Itzstein et aI. , 1993). Blocking NA using the drug zanamivir has
been shown to stop the spread of influenza virus to other cells (Woods et aI. , 1992). The
crystal structue of the protein demonstrates that the NA folds into six, four-stranded
antiparallel beta-sheets, aranged like propeller blades (Colman et aI. , 1983; Varghese et
aI. , 1983). There is a four-fold axs of symmetr and a conserved region at the catalytic
site that binds sialic acid.
Concernng the internal structue, the RNA of segment 7 codes for both matrix
proteins , MI and M2. The MI viral protein is found under the envelope and has a role in
maintaining the structure of the virion. It is also found in the nucleus and cytoplasm of
infected cells and is thought to have a role in downegulating the transcriptase (Murphy
and Webster, 1990). The M2 protein is encoded by a spliced mRNA. M2 is an ion
chanel that is activated by low pH. It is found on the virion surface and in the cell
membrane of virus infected cells. It is found in high copy number in the infected cell and
is essential for virus uncoating.
NS 1 and NS2 are the non-structural proteins found in infected cells. NS 1 is an
RNA-binding protein that is abundant in infected cells and has been implicated in a
number of fuctions. The NSI protein inhibits mRA polyadenylation to shut off host
protein synthesis (Numeroff et aI. , 1998), binds mRNA poly-A tails to inhibit mRA
export (Fortes et aI. , 1994; Qiu and Krg, 1994), and inhibits splicing of pre-
mRNAs(Fortes et aI. , 1994). NS 1 can also bind dsRNA in vitro to prevent activation of
PKR (the kinase induced by IFN) (Lu et aI. , 1995). Influenza virus deficient in NS 1 is
not pathogenic in wild type mice, but is pathogenic in mice lacking an IFN response
(STAT-I- mice) (Garcia-Sastre et aI. , 1 998). The NS2 protein is encoded from a spliced
mRA, and the role ofNS2 is to transport viral RNA into the cytoplasm from the
nucleus (ONeil et aI., 1998). It has recently been renamed NEP (nuclear export protein)
because the protein is found in the virion and is structual (ONeil et aI. , 1998).
NP is a par of the ribonuclear complex that makes up the backbone of the helices
along with PB 1 , PB2 , and P A. It is involved in transport of viral RNA into the nucleus
durng infection and may have a role in transcription and replication, since mutations in
NP cause defects in RNA synthesis (Beaton and Krg, 1986; ONeil et aI. , 1995). The
RNA polymerase is a multi subunit enzyme made up of P A, PB 1
, and PB2 viral proteins
(Fig. 111-1). The proteins each have a nuclear localization signal and they accumulate in
the nucleus once the cell is infected. The stem of the panandle formed by the
complimentar ends of the vRNA is the polymerase complex binding site. Transcription
is initiated by a "cap snatching" mechanism in which the proteins cleave capped RNA
from host cell messages to star the transcription of viral mRNA (Plotch et aI. , 1981). An
as yet undefined protein is necessar to make the complex switch from a transcription
unt to a replication machinery.
Fig. III-I. RNA Polymerase and Surface Glycoproteins of Influenza A.
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Influenza virus is spread from person to person through aerosol. Replication
occurs throughout the respiratory tract, peaking at about 48 hours. Viremia in humans is
extremely rare , as generally the infection is limited to the respiratory tract. Onset of
ilness is marked by symptoms such as headache , chills , and cough. Fever usually begins
soon after and does not decrease until day 2-3. The temperature goes back to normal by
day 6. Birds generally have an asymptomatic infection and shed a lot of virus in the feces
due to replication of virus in the intestinal tract as well as the lungs. Swine show
symptoms such as cough, fever, nasal discharge , and labored breathing (Murhy and
Webster, 1996). Pigs may be the "mixing vessel" where viruses reassort, since both
avian and human viruses can infect them. Influenza can also natually infect horses
seals, whales, and mink. Experimental infections have been studied in mice , ferrets , and
primates (Murhy and Webster, 1996).
5. The Role of Cytotoxic T Lymphocytes in Eradicating Virus Infection.
There are two ars of the acquired immune system that work together to protect the host
and to eradicate viruses. The humoral ar encompasses B lymphocytes and the
antibodies that they secrete, and the cell-mediated response includes CTL that can lyse
virus-infected antigen-presenting cells (APC) and T helper cells , which secrete cytokines.
Neutralizing antibodies can protect cells from being infected by blocking entry of the
extra-cellular virus paricles or promoting virus paricle clearance by Fc-bearing cells
and can eradicate infected cells using antibody-dependent cell-mediated cytotoxicity.
Neutralizing IgA specific for HA or NA is produced in airway secretions of humans in
response to influenza A infection and is detectable for at least 3-5 months post-infection
(Murhy and Webster, 1996). The levels of serum antibodies to HA and NA have
correlated with protection from illness following either natural exposure (Couch and
Kasal , 1983) or experimental infection (Clements et aI. , 1986). Both live attenuated
influenza virus vaccines and inactivated influenza A vaccines induce HA-specific
antibody responses (Ennis et aI. , 1982).
CTL are involved in destroying virus-infected cells and are important in
decreasing virus titers. Recognition of cognate antigen occurs through the T cell receptor
(TCR). The TCR is made up of two chains, either an a polypeptide chain pairs with a p,
or a y polypeptide chain pairs with a '6. The remainder of this section wil focus on the
ap TCR expressing CTL. The ap TCR has a varable region important for antigen
recognition, and a constant region important in T cell activation and membrane
association (Moss et aI. , 1992). CTL become activated to lyse virus-infected cells by
recognition of viral peptides bound to class lor class II major histocompatibility antigens
(MHC) with their TCR. MHC molecules are polymorphic proteins that bind peptides
inside of the cell and present them on the surface of the cell. The N and C-terminal
portions of the peptide bind grooves on the MHC molecule and the TCR generally
recognizes the middle portion of the peptide with its complementary determining regions
(CDR). Class I molecules are expressed on all nucleated cells, while class II molecules
are expressed constitutively only on professional APCs such as dendritic cells
macrophages , and B cells. CTL can express either CD8 or CD4 molecules. CTL
expressing CD8 molecules recognize class I bound viral peptides, while CTL expressing
CD4 molecules recognize class II bound viral peptides. The mechanisms of cytotoxicity
for both subsets include perforin/granzyme, Fas/Fas Ligand interactions , and TNF.
Besides kiling virus-infected cells, CTL are important mediators of cytokine
secretion. IFN-y is a type II IFN primarily secreted by T cells and NK cells. It can
activate mononuclear phagocytes , increase MHC class I and II expression on APCs
promote T and B cell differentiation, activate neutrophils, stimulate NK cytolysis , and
activate vascular endothelial cells. In the lymphocytic choriomeningitis virus (LCMV)
system, CD8 T cells produce IFN-y in response to infection and proliferate extensively
(Gessner et aI. , 1989; Biron, 1994; Cousens et aI. , 1995). IFN-a is an important early
mediator and promotes the conditions in the LCMV model that stimulate IFN-y secretion
(Cousens et aI. , 1999). During influenza infection, IFN-aR-/- mice undergo a systemic
infection, suggesting that IFN-a has a role in the tissue restriction of influenza A virus
(Garcia-Sastre et aI. , 1998). In the influenza system, mice were found to have the
maximal number oflFN-y secreting T cells in the mediastinal lymph nodes (MLN) 7
days post influenza infection (Sarawar and Dohert, 1994), and increases in IFN-
mRA have also been detected at this time point (Baumgarh et aI. , 1994). This
correlates with experiments where human PBMC were stimulated with influenza in vitro.
The increase in IFN-y-secreting cells was found to be mostly CD8+ T cells, and the
increase in IFN-y spot-forming cells (SFC) on day 7 post stimulation correlated with
increased cytotoxicity on that day (Fabio et aI. , 1994).
The balance between the activation and action of CTL to limit virus infections
and the destrction of healthy cells is very important. In several systems, the over-
activation of the immune system is implicated in the pathogenesis of the disease. Thus
homeostasis between the activation of CTL and destruction by CTL must be maintained.
An example of a breakdown in this homeostasis is in dengue virus infection. There is a
higher risk of getting dengue hemorrhagic fever if the patient has been previously
exposed to a different dengue virus serotype (Halstead, 1988). There is evidence of
antibody dependent enhancement of dengue infection. Individuals develop non-
neutralizing antibodies to other dengue serotypes during primar infection and are more
susceptible to severe disease during a second infection with another serotype (Halstead
and O'Rourke, 1977; Halstead, 1979). Memory cross-reactive T cells also are
demonstrable after primary infection. During a secondar dengue infection, T cells were
shown to be activated in vivo and secrete IFN-y, which can support infection ofthe
monocytes by upregulating FcyR (Kurane et aI. , 1991; Mathew et aI. , 1998). By the time
the virus is cleared, the CD8+ T cells are actively increasing in number (Green et aI.
1999), and shock due to capilar leak syndrome occurs as virus is being cleared. This
suggests that the immune system, with CTL , playa role in dengue shock syndrome
(Halstead, 1988; Kurane and Ennis, 1992).
Another example is observed in the influenz system where nude mice actually
live longer than control mice after a lethal dose of influenza virus (Sullivan et aI. , 1976;
Wells et aI. , 1981). This suggests that although the virus infection itself eventually may
destroy the host, host immune responses can playa role in the pathology of virus
infections. To support this theory, FS-RAG- /- TCR transgenic mice that only have T
cells which recognize aa 366-374 on NP of influenza were given a low-dose infuenz
infection, and even in the absence of protective antibodies the infection is eradicated
(Moskophidi and Kioussis, 1998). Virus titers decrease by day 8 , lung pathology is
confined to several foci of inflamation, and the mice survive. However, if high doses
of influenza virus are administered, the ilness is exacerbated, lung pathology is severe
and the percent surival is lower than the Rag 1- mice , which lack all T and B cells
(Moskophidis and Kioussis , 1998).
6. The Role of CTL in Eradicating Influenza Virus Infection in Mice.
The importance of virus-specific CTL in immunity to infuenza A has been well
documented in the murine system. Infuenza virus-specific CTL have been shown to
limit infuenza A virus replication and to protect against lethal influenza A virus
challenge (Yap et aI. , 1978; Wells et aI. , 1981; Taylor and Askonas , 1986; Kuwano et aI.
1988; Mackenzie et aI. , 1989; Kuwano et aI. , 1990). CTL have been recovered from the
lungs of influenz A virus-infected mice (Yap and Ada, 1978) and recovery from
influenza virus infection correlates with clearance by CD8+ CTL (Mackenzie et aI.
1989). After primar influenza infection there are substantial numbers of CTL that are
virus-specific in the bronchoalveolar lavage (BAL) fluid of mice. With a secondar
challenge, CTL precursors (CTLp) proliferate in the regional lymph nodes and are
recruited to the lung to clear the virus (Flynn et aI. , 1998).
Virus-specific CTL clones that recognize epitopes on NP, HA, or NS 1 virus
proteins and influenza virus-stimulated immune splenocytes adoptively transferred into
naive recipients , reduced pulmonar virus titers after influenz virus challenge (Wells et
aI., 1981; Taylor and Askonas , 1986; Kuwano et aI. , 1988; Kuwano et aI.
, 1990).
Furhermore , transfer of CTL clones into influenza A infected mice has been shown by
histology to enhance lung tissue recovery (Mackenzie et aI. , 1989). Our laboratory has
shown that active immunization with an HA fusion protein, that induced HA-specific
CTL but not neutralizing antibody, resulted in a reduction in peak lung virus titers after
virus challenge , and protection against a lethal challenge dose (Kuwano et aI. , 1989). 
vitro, murine epithelial cells can be infected with influenza A virus and killed by CTL
(Nguyen et aI. , 1998).
Much work has been done in transgenic or knock-out mice in order to discern
which cell populations are important during influenza A infection in vivo. Transgenic
mice that lack p-2 micro globulin, and thus have no class I-restricted CTL , have delays in
viral clearance and increased mortality after infection with a virulent strain of influenza
virus (Bender et aI. , 1992). However, these mice have defects other than a simple lack of
CD8+ T lymphocytes. In mice depleted of CD4+ T cells, virus is stil cleared and the
CTLp frequency of influenza-specific CD8+ CTL in the lungs or lymph node is not
altered significantly (Allan et aI. , 1990). However, CD4+ virus-specific T cells may help
compensate for the absence of CD8+ CTL , because the virus is eventually cleared in
CD8+ depleted mice. 2 micro globulin deficient mice depleted of both CD4+ and
CD8+ CTL do not clear virus or surive (Eichelberger et aI. , 1991). Surprisingly IFN-
knock-out mice recover from an influenza H2N2 primar infection as well as control
mice (Graham et aI. , 1993). However, when H3N2-immune IFN-y knock-out mice were
challenged with a HINI subtype influenza virus , they were not able to completely clear
virus by day 7 (Bot et aI. , 1998). Therefore , IFN-y may play an important role in the
memory recall response.
These CD8+ and CD4+ CTL may be killing virus-infected cells and secreting
IFN-y or other anti-viral cytokines to help clear the virus. The mechanism that CD8+
CTL use to kil influenza-infected lung epithelia has been studied extensively. Perforin
or Fas-deficient mice can clear influenza A viruses with or without CD4+ T cells
although there is delayed kinetics (Topham et aI. , 1997). The perf orin-deficient mice
were shown to have enhanced antibody and IFN-y production after influenza infection
suggesting a role for perforin in down-regulating the immune response (Sambhara et aI.
1998). Thus , CD8+ CTL must utilize both mechanisms (and possibly others) to clear
virus.
Additionally, CD4 depleted mice with perf orin -/- bone marrow (thus no perforin-
forming CD8+ T cells) could not clear virus from a Fas -/- influenza-infected respiratory
epithelium, but could from a Fas +/+ influenza-infected respiratory epithelium (Topham
et aI. , 1997). Therefore, mice lacking both the effectors that make perf orin and the
targets that express Fas can not clear virus, ruling out the use of another mechanism for
killng infuenz-infected epithelial cells. A CD4-depleted mouse with perf orin +/+ bone
marow (normal CD8+ effectors) could clear influenza virus from either the Fas-/- or +/+
infected respiratory epithelium (Topham et aI. , 1997). These results suggest that
primarly the Fas and perf orin pathways are utilized in the destruction of target cells
infected with influenza virus.
7. The Role ofCTL in Eradicating Influenza A Infection in Humans.
CTL responding to influenza A infection of humans has also been studied. Human CTL
responses to influenza were analyzed in a study where 63 volunteers were experimentally
inoculated; virus shedding, serum antibody, and CTL responses were measured.
V olunteers with detectable levels of serum antibody did not shed more than a trace of
virus; those without detectable antibody had low levels of viral shedding if they had CTL
responses specific for influenza (McMichael et aI. , 1983). This suggests that in the
absence of antibody, CTL can playa role in defense from virus infection. In another
report the cytokine responses in the nasal lavage of experimentally infected volunteers
were analyzed at various times post-infection (Hayden et aI. , 1998). IL-6 and IFN-a
peaked at day 2 , correlating with viral titers and symptom scores. TNF -a peaked later at
day 4 , and IL-8 increased by day 6 (Hayden et aI., 1998).
In humans , CTL have roles in many other virus infections. For example , humans
with T cell deficiencies often have uncontrolled EBV infections that can become
disseminated and even lethal (Purilo et aI. , 1992). CTL specific for EBV have been
isolated from both patients with acute and chronic EBV -infections (Couedel et aI. , 1999).
There is also literature on CTL isolated from HIV - infected patients that were found to
recognize HIV -infected cells (Plata et aI. , 1987; Walker et aI. , 1987). A correlation
between the increase in HIV -specific CD8+ T cells and the decrease in viral burden
leading to the asymptomatic phase of HIV has been demonstrated (Borrow et aI. , 1994;
Koup et aI. , 1994). Additionally, progression towards AIDS has been correlated with a
decrease in the HIV -specific CTL precursor frequency (Carichael et aI. , 1993). It has
also been shown that prior to prolonged viral suppression with anti-retroviral therapy,
HIV infected individuals have CD4+ CTL specific for HIV (Pitcher et aI. , 1999). CD4+
and CD8+ T cells have been shown to recognize Env, Gag, and Pol HIV proteins (Kundu
and Merigan, 1992). HSV is another virus that infects humans , and virus-specific CTL
have been detected (Posavad et aI. , 1996). A correlation between CTL and clearance of
HSV -2 from recurent genital lesions has been demonstrated (Koelle et aI. , 1998).
Control of rhinovirus infections has been reported to involve CTL. Enhanced IL-2 and
IFN-y production were demonstrated in the PBMC of individuals experimentally infected
with rhinovirus (Hsia et aI. , 1990). Experimental rhinovirus infection in humans was also
shown to induce T cell responses in the PBMC (Hsia et aI. , 1990).
B. THE CYTOTOXIC T LYMPHOCYTE MEMORY REPERTOIRE SPECIFIC
FOR INFLUENZA A.
In order for CTL to kil virus-infected APCs, they need to be either induced to become
effector cells from naive cells or to be present in the memory population. NaIve T cells
can surive long-term in the periphery if they receive TCR ligation through autologous
MHC molecules (Freitas and Rocha, 1999). For naIve T cells to be induced to become
virus-specific effectors, they need a signal by the autologous MHC-restrcting allele
containing antigenic peptide, and a second signal from co-stimulatory molecules such as
the B7 family members (Linsley et aI. , 1990). A longer period of stimulation is necessary
for naIve cells to produce cytokines than for effector or memory cells (Bachman et aI.
1999). Once naIve cells are stimulated to become effector cells their role is to quickly
destroy virus-infected cells. This may lead to recovery but also may result in
immunopathology, as described earlier. Eventually these cells may enter the long-lived
memory T cell pool.
1. The CTL Repertoire Specific for Influenza A in the Mouse is Limited.
After a primar infection with influenza virus, mice generate an increased influenza-
specific CTLp frequency that peaks on day 7 and decreases by day 14. The memory T
cells that persist can remain for the life of the mouse (Effros et aI. , 1977; Askonas et aI.
1982; Owen et aI. , 1982; Ada and Jones , 1986; Flynn et aI. , 1999). There are different
hypotheses on how the long-lived memory T cells are maintained. It has been proposed
that antigen persists , possibly on follcular dendritic cells (DC), allowing constant re-
stimulation of the memory T cells (Rooijen, 1992). However, no influenza virus RNA is
detected by PCR two weeks post-infection (Eichelberger et aI. , 1991). Another group has
shown in the mouse that the memory T cell population changes after subsequent infection
with different viruses (Selin et aI. , 1998). Cross-reactivity with the low-affnity epitopes
of other viruses may be a means of retaining influenz A-specific T cell memory, since
memory T cells have been shown to be inducible with less signal (Beverly, 1990;
Tanchot et aI. , 1997). There is also the theory that T cells recirculating though activated
environments rich in cytokines wil lead to bystander activation of T cells. This theory
relies on the fact that CD8+ T cells can be isolated from the lungs of influenza-
infected
mice that are not pathogen-specific , but have CD44 L-selectin
low 
activation markers
(Ho and Doherty, 1993). On the other hand during acute infection of the HY-transgenic
mouse with LCMV , the HY -specific cells do not enter blastogenesis and are diluted at the
time of acute infection (Zarozinski and Welsh, 1997). Furhermore , recent techniques
have been developed to enable a more accurate enumeration of virus-specific CTL during
an acute LCMV infection and most of the activated T lymphocytes were virus-specific
(Butz and Bevan, 1998; Murali-Krishna et aI. , 1998).
The CTL repertoire specific for influenza A viruses in inbred mice has been
shown to be limited during primar and secondar infections. It has been reported that
there are low or non-responder class I alleles for influenza A CTL responses (Bennink
and Yewdell , 1988). For example , the L d molecule was the restricting allele for only one
of the influenza A viral protein expressing vaccinia constructs tested (NS 1) (Bennink and
Yewdell, 1988). Furhermore, D , D , and K were all found to be non-responder alleles
for CTL responses to NP (Pala and Askonas, 1986). In both mice and humans the CTL
responses detected in bulk culture were previously reported to be primarily directed at NP
(Townsend et aI. , 1984; Townsend and Skehel , 1984; Yewdell et aI. , 1985; McMichael et
aI. , 1986). The recognition of influenza virus by CTL in inbred mice was commonly
found to be limited to immunodominant epitopes on one or two viral proteins (Townsend
et aI. , 1986; Vitiello et aI. , 1996). During secondar exposure to influenza, CTL that
recognize immunodominant epitopes again markedly expand (Flynn et aI. , 1999).
Furhermore , nonimmunodominant epitopes on NP have also been reported, but
immunization with such epitopes did not protect mice from subsequent challenge as
effciently as immunization with the immunodominant epitope (Ouka et aI. , 1996).
The impact of a limited T cell repertoire specific for a virus (e.g. to one
immunodominant epitope), has been studied in mouse models. When the potential
repertoire was limited by using a mouse with a rearanged p-chain, influenza could stil
be cleared with only a slight delay; but the epitopes recognized by CTL were different
than that of wild type mice (Daly et aI. , 1995). Theoretically, having CTL that recognize
many different epitopes would be beneficial in case a mutation in the immunodominant
epitope occurred. Ouka et al. found that immunization with both the immunodominant
and subdominant epitopes of influenza was more protective than immunization with the
immunodominant epitope alone (Ouka et aI. , 1996). This would argue that a broad
response may be beneficial.
Acute LCMV infection of BALB/c mice generates T cells specific for NP 118-
126 which is restricted by L . However, spleen cells which recognize a subdominant
epitope GP 283-291 can clear a chronic LCMV virus infection from H- dm2 mice (L 
negative), suggesting that subdominant epitopes playa role in clearance also (Most et aI.
1997). Oldstone et ai. have shown that mice infected with LCMV variants which have
changes in the immunodominant epitope, develop a CTL response to a different epitope
on another protein (Oldstone et aI. , 1995). This suggests that although mice have a
limited repertoire to some viruses, there is flexibilty in the immune system allowing the
generation of a response to a once silent epitope.
2. The CTL Repertoire Specific for Influenza A Viruses in Humans.
Our laboratory has previously shown that long-lived memory T cells exist in humans.
Vaccinia virus-specific T cells can remain in the PBMC many years post-vaccination for
small pox (Demkowicz, 1993). In another system , the live attenuated measles vaccine
provides long-term protection (Dhib-Jalbut and Jacobson, 1994). Also , volunteers who
received experimental dengue vaccination exhibited CTL memory several years post
vaccination (Green et aI. , 1993; Zeng et aI. , 1996; Green et aI. , 1997). In several donors
we have also observed influenza-specific memory T cells that recognize the same viral
proteins up to a decade later. But these donors may have been exposed to influenza A
virus in the intervening years (unpublished data by Julie Jameson).
An early study using influenza stimulated bulk cultues of PBMC of six humans
demonstrated that 6 of 6 donors ' PBMC recognized NP , 4 of 6 recognized PB2 , 6 of 6
recognized M 1 , 1 of 6 recognized M2 , and there was no recognition of the other six viral
proteins (Gotch et aI. , 1987). After this study was published, many groups focused on
NP or MI , often referring to them as the immunodominant influenza viral proteins.
Previous groups had also identified several CTL clones in humans that recognize
infuenza A virus epitopes , (see Table 1-3). Most of these CTL clones were isolated from
different individuals and were specific for epitopes on NP. The MI aa 58-66 epitope
which is HLA-A2. 1 restrcted was recognized by the PBMC of humans in several studies
(Gotch et aI., 1987). Since the A2. 1 allele is a common HLA allele in the Caucasian
population, ths epitope has been studied extensively and been referred to as an
immunodominant epitope by many groups. It is important to define influenza viral
protein and epitope recognition at the clonal level in order to determine if the human CTL
memory response is restricted to a small number of immunodominant epitopes on a few
proteins, or to a wider number of epitopes on many different viral proteins. It remained
; to be determined whether a single individual has a multi specific memory response , and
whether many different HLA alleles are used by the APCs of each individual to present
influenza A peptides. Furhermore , once the CTL become established as a par of the
host's repertoire , it is important to determine whether they continue to persist over time.
Table 1-3. Previously Characterized Human CD8+ CTL Epitopeson
Influenza A Viral Proteins.
HLA
Viral Restricting Amino Amino Acid Publication
Protein Allele Acids Sequence
NSI A201 122- 130 AIMDKNIIL Int. Immunol. (1995) 7:597
A201 58- GILGFVFTL Nature (1987) 326:881
44- CTELKLSDY J. Immunol. (1993) 151:5930
A68. 91- KTGGPIYK Proc. R. Soc. London (1991)
244:169
265-273 ILRGSV AHK J. Immunol. (1993) 151:5930
B37 342-351 FEDLRVLSFI J. Exp. Med. (1986) 164:1397
380-388 ELRSRYW AI Eur. 1. Immunol. (1993)
23:447
B2705 383-391 SRYW AIRTR Int. Immunol. (1990) 2:311
PBI 591-599 VSDGGPNL Y 1. Immunol. (1993) 151 :5930
C. HETEROTYPIC IMMUNITY SPECIFIC FOR INFLUENZA A.
If an influenza virus variant evades neutralizing antibody, other components of the
immune system, such as CTL , can decrease morbidity and mortality (Schulman and
Kilbourne, 1965; Aner et aI. , 1978; Couch and Kasal , 1983; Nguyen et aI. , 1999). This
decrease in ilness associated with challenge by influenza viruses of a different subtype is
characterized as heterotypic immunity. Heterotypic immunity to influenza A has been
observed in mice and humans (Schulman and Kilbourne , 1965; Anker et aI. , 1978; Couch
and Kasal , 1983).
1. Mice Can Recognize Influenza A Virus Strains of Differing Subtypes.
Our laboratory has previously shown that adoptive transfer of a subtype cross-reactive
NSI-specific CTL clone reduced virus titers in mice infected with HIN1 , H2N2 , and
H3N2 influenza viruses (Kuwano et aI. , 1990). Mice immunized with an H3N2-subtype
of influenza virus were protected during challenge with a virulent H3N8 virus (Riberdy et
aI. , 1999). When T cells were depleted during the H3N8 infection, there was a delay in
viral clearance. Furhermore, Ig- IlMT H3N2-immune mice could clear low doses of the
virulent H3N8 strain, suggesting that the cross-reactive CTL could decrease ilness 
there was enough time to expand to large enough numbers (Riberdy et aI. , 1999).
These and other findings revive the question regarding the effector mechanisms of
heterotypic immunty. Heterotypic immunty occurs in the absence of neutralizing
antibodies and it is thought to be mediated by CD8+ CTL. Nguyen et al. found that
protection from lethal heterotypic infuenza virus challenge by the mucosal route
correlated with heterotypic CTL in the mucosa-associated lymphoid (MAL) tissue
(Nguyen et aI. , 1999). Long-lived CTL memory was induced at this site after mucosal
immunization (Nguyen et aI. , 1999). The memory CTL can be activated, since secondary
heterotypic influenza virus challenge has been shown to lead to a massive proliferation of
NP 366-374 specific CTL in C57BL/6J mice during acute infection (Flynn et aI. , 1999).
However, p2-m -/- mice have heterotypic immunity (Eichelberger et aI. , 1991; Bender et
aI. , 1994; Epsteinet aI. , 1997), and depletion of CD8+ T cells in the nose, trachea, or lung
by mAb led to only a parial abrogation of heterotypic immunity (Liang et aI. , 1994).
There may be an important balance between CD4+ and CD8+ T cells in protection from
heterotypic influenza challenge. Furthermore, their location (ex. in lungs or MAL),
precursor frequency, and virus dose all seem to playa role in protecting against
subsequent challenge. Another factor involved may be the Thl or Th2 nature of the
cytokine environment. It was recently observed that stimulation with inactivated virus
vaccine initiated a Th2 response that could not clear heterotypic influenza virus infection
however if a Thl environment was established (+IL- IL-4) then a heterotypic infection
could be cleared (Moran et aI. , 1999).
2. Heterotypic Immunity Specific for Influenza A Viruses in Humans.
There have been few reports concerning cross-subtype protection of humans later
infected with an infuenza A virus of another subtype. One study observed Japanese
students durng the 1977-78 infuenz season. When an HINI virus strain infected
primar and middle school students in December of 1977 , significantly fewer students
were infected and sick from the H3N2 virus subtype that caused another epidemic a
, month later as assessed by HAl antibodies and clinical features. This suggests that
previous infection with the HINI virus conferred cross-reactive immunity (Sonoguchi et
aI., 1985). It is likely that the H3N2 virus escaped the neutralizing antibody response to
the HINI virus so this protection was likely to have been mediated by cross-reactive
, CTL. Couch et ai. followed individuals who had a documented H3N2 infection over a
four year time span. He found that resistance to a homologous virus strain lasted at least
4 years (Couch, 1975), and this immunity also extended to a different strain ofH3N2
(Couch and Kasal, 1983). In other studies he observed the heterologous protection for up
to 7 years (Couch and Kasal , 1983), but this did not occur with all strains. The history of
infuenza epidemics provides another example. In the early H3N2 era, persons with a
previous H2N2 infection had a significantly lower attack rate upon first exposure to the
new H3N2 subtype of influenza virus infection (Hope-Simpson, 1971; Hope-Simpson
1972; Gil and Murhy, 1977). This immunity may have been due to NA2 specific
antibodies as well as T cell memory responses.
With the possibilty of point mutations and reassortment, influenza A viruses of
swine and avian origin have the potential to evade neutralizing antibody just as the
HIN1 , H2N2 , and H3N2 human influenza viruses have. There have already been several
examples of direct transmission of non-human influenza A subtypes into humans.
Durng the winter of 1976 a soldier at Fort Dix died from an infuenza A virus infection
(A/ew Jersey/76) that was later characterized as having HA and NA glycoproteins
(HswlNI) similar to swine species. A serological surey found that several hundred
infections had occured and at least 12 clinical cases were observed with person-to-
person transmission suspected (Langmuir and Schoenbaum, 1977). This ignited the fear
that this virus would cause a global pandemic like the 1918 swine-like virus had caused.
Therefore , health offcials ordered the development of an influenza A vaccine. Once the
vaccine was finally administered , it was found to increase the chances of developing
Guilain-Bare syndrome, and the program was terminated. Fortunately, there was no
further spread of the swine virus outside of Ft. Dix.
3. H5Nl Subtype Influenza A Virus Infection of Humans in 1997.
The theat of an epidemic by a novel subtype of infuenza occurred again in 1997 when
an H5NI influenza A virus was isolated from a 3 year old boy in Hong Kong. This child
did not survive the infection and his was the first of six deaths in Hong Kong due to
H5Nl influenza A virus infection (Doepel , 1998). The virus isolated was found to be
similar to avian H5N 1 viruses and those infected were known to have had contact with
chickens (Suarez et aI. , 1998; Subbarao et aI. , 1998). All eight segments of the 1997
H5NI influenza A virus were derived from an avian virus and had varing degrees 
conservation with human strains (Subbarao et aI. , 1998). The internal viral proteins had
the highest percent of conservation ranging from 83.3% homology for PB2 to 91.2%
homology for MI (Subbarao et aI. , 1998).
This was the first documented instance of an H5 subtype of influenza A virus
natual human infection and of direct transmission of this virus from birds to humans.
Avian viruses usually utilze the sialic acid a2 3 galactose determinants, whereas human
strains generally use sialic acid a2 6 galactose determinants (Webster, 1999). The isolate
from this child (AlK/156/97) was found to be virulent in chickens causing a systemic
infection (Subbarao et aI. , 1998). Viral antigen was recovered from blood vessels
pulmonary capilar endothelium , and macrophages of chickens infected with the H5N 
isolate (AlHK/156/97)(Subbarao et aI. , 1998). Other H5 virus isolates have been
previously detected in chickens and waterfowl in Mexico, and in 1983-84 there was an
outbreak of virulent H5N2 virus in U.S. poultry fars (Webster et aI. , 1992). The viremia
caused by these H5 viruses has been observed in naive mice challenged with another
virulent subtype of infuenza virus (H3N8); virus was isolated from the brain, liver, and
spleen (Riberdy et aI. , 1999).
It was important to determine whether human cross-reactive CD8+ and CD4+
CTL would recognize targets infected with influenza A virus strains of swine and avian
species including the H5Nl virus strains recently isolated from patients in Hong Kong.
Older children and adults living in the United States of America and elsewhere in the
world in 1997 possess influenz A virus cross-reactive memory T cells that recognize the
human subtypes , but some of these T lymphocytes may also recognize epitopes on the
H5Nl avian-derived virus strains which caused human ilness. If such heterotypic CTL
existed in high enough precursor frequency they may restrict virus replication and
prevent severe ilness and morbidity. Since 2/3 of the people infected with the H5NI
avian influenza virus surived, it is possible that some humans have long-lived cross-
reactive immunty to this virus.
D. INFLUENZA VACCINES HAVE BEEN DEVELOPED TO BOOST CTL.
The curently licensed influenza vaccine is composed of formalin-inactivated , detergent-
disrupted virus paricles. This vaccine is designed to induce antibodies that recognize
surface HA and NA of the homologous and closely related influenza A virus strains.
However, if a variant strain emerges, neutralizing antibodies could not provide protection
because the major antigenic epitopes are on the variable surface glycoproteins. This can
be demonstrated by the yearly outbreaks of diverse influenza strains that mutate and
evade neutralizing antibodies, causing morbidity and approximately 10 000 deaths a year
in the U.S. (Murhy and Webster, 1996). As a strategy to deal with this antigenic
variation, our laboratory has focused on the development of influenza A vaccines that
also augment virus cross-reactive T lymphocyte memory. CTL memory may be a second
line of defense against serologically distinct influenza viruses by clearing infected cells
and thereby decreasing the severity of ilness (Kuwano et aI. , 1989; Kuwano et aI. , 1990).
It is important to lear how to induce and augment cross-reactive CTL responses with
kiled or subunit vaccines in general and with the influenza vaccine in paricular because
of the high degree of antigenic variation between virus strains.
1. Getting Antigen into the Class I Pathway to Activate CTL.
The key to inducing a strong CTL response is to get the antigen presented by the class I
pathway of the APC. The class I pathway usually only presents antigens synthesized in
the cytoplasm, such as endogenous self antigens and viral proteins produced by live virus
(reviewed in (Rock, 1996)). Proteins found in the cytoplasm are degraded by
proteasomes and proteases. The resulting oligopeptides can then be transported to the
endoplasmic reticulum (ER) by means of the transporter associated with antigen
processing (TAP), where the peptides can be further modified. Next
, peptides bind to
MHC molecules , stabilizing the MHC and the complex traffics to the surface of the cell.
If an adjuvanted paricle or liposome can help protein antigens enter into the cytoplasm , a
peptide epitope may be able to be presented by the class I pathway. Some groups have
also targeted peptides to the ER in order to skip proteolysis and transport (Restifo et aI.
1994). Another way that an exogenous antigen is capable of entering the class I pathway
is by penetrating into the cytosol on its own. Examples of such antigens are fusogenic
proteins on viruses that allow membrane entry (Yewdell et aI.
, 1988). Lastly, there are
some cell types that have been implicated in exogenous antigen presentation by MHC
class I molecules. These include certain types of macrophages and dendritic cells.
Although the inactivated influenza vaccine has not been shown to induce CTL
, it can
elicit CD8+ CTL responses if presented by dendritic cells (Bender et aI.
, 1995).
2. Vaccine Strategies Previously Developed to Induce CTL.
There have been several vaccination strategies developed that attempt to induce CTL
activation by vaccination. Liposomes were created to mimic the natural virus infection
using a lipid bilayer containing the viral glycoproteins. The liposomes were reconstituted
with infuenza glycoproteins HA and NA and delivered intranasally (Ln.) or
intramuscularly (i. ) to mice (Guink et aI. , 1989). Both routes of vaccine administration
elicited antibody responses and provided protection (Guink et aI.
, 1989). CTL are also
induced and activated by the presentation of the liposomal antigens on both macrophages
and subsequently dendritic cells (possibly through the transfer of antigen) (Nair et aI.
1994).
Another vaccination strategy utilizes plasmid DNA encoding antigenic proteins to
induce both humoral and cell-mediated responses. The DNA vaccine is either dissolved
in saline and delivered by injection or attached to gold beads and delivered by the gene
gun. An i.m. injection of a plasmid encoding NP induced a strong T cell response to the
NP 147- 155 epitope in Balb/c mice (Fu et aI.
, 1999). The mice were also protected
against a lethal infection with an influenza virus of another subtype (H3N2) (Fu et aI.
1999). This method allows for the presentation of antigen by both the class I and class II
pathways, since both endogenous and exogenous antigen are made. DNA vaccination
with NP was found to prime CD8+ CTL and CD4+ T helper cells (Ulmer et aI.
, 1998). If
these NP DNA vaccinated mice were depleted of either CD4+ or CD8+ T cells by mAb
there was stil protection against subsequent heterotypic challenge (Ulmer et aI.
, 1998).
Another vaccine approach is the use of a pariculate adjuvant called immune-
stimulating complexes (Iscoms). Iscoms are cage-like paricles approximately 35 nm in
diameter made up of cholesterol
, phospholipid, the antigen of interest, and Quil A
(Morein et aI. , 1984). Iscoms are taken up by APCs such as macrophages
, monocytes
, .
dendrtic cells, and naIve B cells (Morein et aI. , 1994). They can enhance Thl and Th2
cytokine production by antigen-specific T cells (Morein et aI.
, 1995) and disseminate
rapidly from the injection site to draining lymph nodes (Watson et aI.
, 1989). Other
groups have shown that Iscoms can upregulate MHC class II molecules on monocytes
(Watson et aI. , 1989). Inside APCs , Iscoms associate with lipid membranes , thus
localizing to the cytosolic or vesicular compartments. This allows for presentation by
both class I and class II MHC molecules, but class I presentation is inhibited in T AP-
deficient T2 cells , suggesting a role for TAP (Binnendijk et aI. , 1992). Iscoms have been
used with various antigens and tested for antibody responses, CTL responses , and
protection in animal models (Bar and Mitchell , 1996).
3. Immune Responses to the Flu-Iscom Vaccine in Mice.
Immunization of mice (i. ) with Iscoms incorporating the HA and NA influenza
surace glycoproteins elicited antibody (IgM , IgG, and IgA) responses that were
comparable to antibody titers elicited during influenza virus infection (Jones et aI. , 1988;
Lovgren and Morein, 1988). The influenza-specific antibody-secreting cells were found
in the lung along with influenza-specific CTL precursors post-vaccination. After
vaccination with the HA, NA Iscom vaccine , mice were protected from subsequent i.
challenge with influenza virus (Sundquist et aI. , 1988; Lovgren et aI. , 1990). Influenza
NP was integrated into Iscoms by LPS attachment and protected mice when delivered
orally (Bar and Mitchell, 1996). Later, Iscom vaccines were formulated with
inactivated, disrupted influenza virus (Flu-Iscom). Flu-Iscom vaccination was shown to
induce antibody and CTL responses in mice and induce heterotypic immunity against
infuenza A virus challenge (Sambhara et aI. , 1998). Flu-Iscom vaccinated mice had a
10-fold higher hemagglutination inhibition titer than influenz monovalent subunit
vaccinated mice and were protected from mortality by a different subtype of influenza A
virus challenge than the vaccinating strain (Sambhara et aI. , 1998). In another system
recently, an Iscom vaccine incorporating the surface glycoproteins of the AlHong
Kong/156/97 (H5N 1) strain was demonstrated to provide protection in roosters
challenged with the virulent H5Nl influenza virus (Rimmelzwan et aI. , 1999). An
increase in the H5-specific antibody titer was observed, but CTL activity was not
assessed (Rimmelzwan et aI. , 1999).
4. Immune Responses to the Flu-Iscom Vaccine in Humans.
Our laboratory has reported increases in influenza-specific bulk cultue CTL memory in
the PBMC of human vaccine recipients who received Flu-Iscom vaccines and vaccines
with empty Iscomatrix paricles mixed with inactivated influenza virus (Flu-Iscomatrix).
(Ennis et aI. , 1999) In a double-blind study, only 5% of the donors who received a single
dose of the standard influenza vaccine (Fluzone) had an increase in CTL bulk cultue
cytotoxicity, but 50% of the Flu-Iscom and 30% of the Flu-Iscomatrix recipients had
increases in influenza A virus-specific CTL cytotoxicity. These increases in the kiling of
influenz-infected B-LCL by bulk cultue PBMC could be due to increases in the number
. :
of CTL specific for influenza or possibly due to an increase in the avidity of memory
cells to influenz A epitopes. It is important to discern if these increases in cytotoxic T
cell activity were due to an increase in influenza virus-specific CTL post-vaccination
, and
if these CTL can be activated to secrete IFN-y upon exposure to influenza virus.
E. THE ROLE OF y'6 T LYMPHOCYTES IN INFLUENZA A VIRUS
INFECTION.
The importance of T cells in protection from influenza A virus infection is well
established, but the role of the y'6 population of T cells has not been well described.
Although ap TCR expressing CTL make up most of the T lymphocytes in the blood
there is a population ofy'6 TCR expressing cells , usually 1- 10% of the PBMC , whose
fuction in viral infections is not well understood. y'6 TCRs are CD3 + , and the lengths
of the y'6 TCR CDR3 are closer to that of immunoglobulins, suggesting a different type of
antigen recognition than by ap TCRs (Rock et aI. , 1994). In mice , y'6 T cells with
distinct TCRs are localized to different tissues. For example, the invarant Vy3N'61 TCR
is localized to the skin, while the Vy4N'61 TCR is found in the reproductive tract and
tongue (Boismenu and Havran, 1998).
Extensive studies in humans have shown a more complicated distribution. In
general the V'61 subset makes up 30-60% ofthe epithelial y'6 T cells and only 1-20% of
blood, while the V'62 subset makes up 10- 30% ofthe epithelial y'6 T cells and 50-90% of
the blood y'6 T cells (Wallace et aI. , 1995). Human blood y'6 T cells are mostly Vy9V'62
TCR+ with extensive diversity at the CDR3 region (Casorati et aI. , 1989). This
population ofy'6 T cells has been shown to proliferate in response to mycobacteria and to
be activated by nonpeptidic antigens such as alkyl phosphate molecules, a
triphosphorylated complex, and prenyl phosphate antigens (Constat et aI. , 1994; Tanaka
et aI. , 1994; Bukowski et aI. , 1995; Burk et aI. , 1995; Bukowski et aI. , 1999). Recently it
has been shown that this recognition relies on the junctional regions of the y chain
, along
with V'62 pairing (Bukowski et aI. , 1998). Most y'6 T cells are CD4-CD8- , but there are
CD8+ and CD4+ subsets. Similar to ap T cells , y'6 T cells can secrete cytokines such as
IL- , IL- , and IFN-y, can upregulate activation markers such as CD25 and CD69
, and
can be cytotoxic to APCs infected with viruses or bacteria (Wallace et aI.
, 1995).
1. y'6 T Lymphocyte Responses Specific for Influenza in the Mouse.
y'6 T lymphocytes expressing Vy4 and Vy7 are resident in the mucosal surfaces of the
lung in C57BL6/J mice (Carding et aI. , 1990). When C57BL6/J mice are infected with
infuenza A H3N2 subtype virus y/'6 T cells increase in number in the BAL after the
infection has resolved (days 10- 13) (Carding et aI. , 1990). After influenza virus infection
with the X-31 strain (H3N2), an expansion of the resident Vy4 population is seen up to
day 13 , and after day 13 an influx ofVy2 cells take over (Carding et aI.
, 1990). When
mice were initially infected with a H3N2 influenza virus and then were given a HINI
secondar influenz A infection one month later y/'6 T cells were detected in the BAL by
day 5 , exhibiting a more rapid response than after challenge with a divergent influenza B
virus (Allan et aI. , 1992). This suggests that there may be either memory y/'6 T cells or
that the memory ap T cells localize the y'6 T cells to the site of infection faster after
secondar challenge. Furhermore, mice infected with different strains of influenza have
different Vy expression
, suggesting specificity (Carding, 1990). In vitro work on
infuenza virus X-31 (H3N2)-immune TCR P-/- mouse y'6 T cell hybridomas has shown
that they produce IL-2 in response to influenza A and B infected cells , but not from cells
infected with other viruses. No response could be detected to any of the influenza A
virus proteins expressed in vaccinia constructs. These hybridomas seemed to recognize
HSP-60 (Ponniah et aI. , 1996).
Trehalose 6 dimycolate (TDM) is a component of the mycobacterial cell wall
and treatment with TDM leads to the accumulation of y'6-expressing cells in the lung.
When mice are treated with TDM, they acquire resistance to infuenza infection. These y'6
cells are cytotoxic to targets transfected with either the HI or H3 subtype ofHA, but in a
MHC non-restricted fashion (Hoq et aI. , 1997). Furthermore, TDM treatment ofTCR '6-
/- (no delta chain) mice prior to influenza infection did not provide protection in
C57/BL/6J mice and provided only slight protection in Balb/c mice (Hoq et aI. , 1999).
This suggests that the protection from influenza infection withTDM treatment is parially
mediated by y'6 T cells. y'6 T cells have also been shown to playa major role during other
pulmonar diseases; for example Nocordia asteroides resulted in death within 14 days
in TCR '6 -/- mice, but control mice could clear the pathogen (King et aI. , 1999).
2. y'6 T Lymphocytes Responses in Humans.
Several groups have reported increases in y'6 T cells in humans after a viral infection or
else isolated y'6 T cell clones that recognize and kill virus infected APCs. The
mechansm of these expansions or the recognition by the T cells has not been fully
resolved. IL- 12 has been shown to activate human y'6 T cells in vitro through a TNF-a
dependent mechanism (Veta et aI. , 1996). y'6 T cells have been analyzed in several
human infections , such as Lyme disease (Vincent et aI. , 1998), HSV - 1 infection
(Maccario et aI. , 1993), EBV infection (Hacker et aI. , 1992), and HIV infection (Boullier
et aI., 1997). Lyme disease is caused by a spirochete 
Borrelia Burgdorferi transmitted by
a tick that causes a nonspecific febrile illness that can become a chronic synovitis if not
treated effectively. There are increased numbers ofy'6 T cells in the synovial fluid
(Vincent et aI. , 1996), and y'6 T cells expand rapidly when exposed to Borrelia, especially
if dendritic cells and IL-2 are present (Vincent et aI. , 1998). The clones analyzed were
V'61 paired with various Vy chains and the antigen they recognized was thought to be a
lipoprotein (Vincent et aI. , 1998).
In another system, the PBMC ofHSV- 1 immune donors were stimulated with
autologous HSV - 1 infected cells, and lysis of infected targets was reported and found to
be partly due to y'6 CD8+ T cells (Maccario et aI. , 1993). It was also reported that
Vy9N'62 T cells from HSV -seropositive donors could grow out if cultued with HSV-
infected cells (Bukowski et aI. , 1994). The y'6 T cells were able to lyse HSV- infected
targets in a non-MHC-restricted fashion (Bukowski et aI. , 1994). It is interesting that
these T cells were also able to lyse vaccinia virus-infected targets, suggesting that a
ligand may be induced by virus infection. Furhermore, this response was not blocked by
anti-HSP antibodies. Murine y'6 T cell clones that recognize glycoprotein 1 on HSV-
were also isolated and found to be MHC-unestricted (Johnson et aI. , 1992).
In acute EBV infections , the percentage ofy'6 T cells in the PBMC is increased
and even remains elevated durng the convalescent phase (Paoli et aI. , 1990). There is a
population of CD4- CD8- V'61 T cells that respond to either autologous or allogeneic
EBV -transformed B cell lines , but cell-cell interaction is necessar (Orsini et aI. , 1993).
This response is independent of y chain utilization. y'6 T cells with another type of TCR
Vy9N'62 have been shown to be able to lyse and proliferate in response to the Daudi cell
line (EBV -associated Burkitt' s lymphoma) (Fisch et aI. , 1990; Fisch et aI. , 1990; Fisch et
aI. , 1992; Hacker et aI. , 1992; Bukowski et aI. , 1995). If antibodies were used to block
the HSP 60 family, there was no outgrowth of this T cell subset which suggests a role for
this molecule in y'6 T cell stimulation (Fisch et aI. , 1990; Selin et aI. , 1992; Kaur et aI.
1993).
The number of circulating y'6 T cells is also increased in the PBMC of HIV-
infected adults (Autran et aI. , 1989; Paoli et aI. , 1991; Maria et aI. , 1992). The expanded
y'6 T cell population in the periphery utilizes the V'61 gene , while the V'62 expressing y'6
cells are underrepresented there (Boullier et aI. , 1997). These y'6 T cells have been
reported to express HLA-DR (Kabelitz et aI. , 1991), CD8 (Paoli et aI. , 1991), and CD38
(Boullier et aI. , 1995). More V'61 + cells from HIV- infected patients ' PBMC secreted
TNF-a and IFN-y upon stimulation than from control PBMC (Bouller et aI. , 1997). The
role of y'6 T cells in human diseases remains to be determined.
Many groups have speculated how the y'6 T cells recognize the virus-infected
cells. In the case of HSV 
-specific Vy9N'62 T cells , the lysis of infected targets could be
blocked with an antibody to the TCR and also with an antibody to CD3 (Bukowski et aI.
1994). This suggests that the y and '6 chains are important for the activation ofy'6 T cells.
Recently, natual killer inhbitory receptors were found to be expressed on Vy9N'62 
cells (Fisch et aI. , 1997; Halary et aI. , 1997; Baker et aI. , 1998; Norris et aI. , 1999). The
Vy9N'62 cells which were lytic expressed the natural kiler inhibitory receptors while
those without killing activity did not express the inhibitory receptor (Halar et aI. , 1997).
The kiler inhibitory receptors were found to inhibit lysis of MHC class 1+ tumor B cell
lines by the Vy9N'62 T cells. These receptors were not expressed on the V'61 subset of
y'6 T cells (Fisch et aI. , 1997). y'6 T cells that express the natural killer inhibitory
receptors may have a role in recognizing tumor cells that lack MHC class I expression.
F. THESIS OBJECTIVES.
1. The first objective of my thesis project was to determine the human CTL
repertoire to influenza A virus by isolating and characterizing cytotoxic T lymphocytes
from human donors.
2. Next, I used the CTL lines to determine whether human CTL lines recognize
cells infected with non-human viruses, such as avian and swine species. PBMC were
stimulated in bulk culture to look at recognition of these non-human viruses. I
characterized the epitopes that these CTL recognized to analyze why they do or do not
recognize the virus strain.
3. I wanted to determine whether these CTL could be boosted by an influenza
vaccine comprised of Iscom paricles and inactivated virus. I first used in vitro
techniques to analyze cytotoxicity, and then I analyzed the PBMC from volunteers in a
vaccine trial. The number of IFN-y secreting cells in the PBMC were analyzed at several
time points post-vaccination.
4. y'6 T cells have a role in resolving influenza A infection or healing injured
tissue. I determined whether they could recognize influenza-infected cells, upregulate
activation markers , and secrete IFN-y. I also analyzed whether these responses could be
blocked by anti-class I mAbs or by inactivating the virus.
CHAPTER 2
MATERIALS AND METHODS
A. VIRUSES
Influenza A viruses, AlPuerto Rico/8/34 (HIN!) and AlJapan305/57 (H2N2) were
kindly provided from the Division of Virology (Bureau of Biologics, FDA, Bethesda
MD). Influenza A viruses AlJohanesberg/33/94 (H3N2) and AlTexas/36/91 (HIN1)
were obtained from Paster Merieux Connaught (Toronto, Ontario). A/ong Kong/156/97
(H5NI) and AlHong Kong/483/97 (H5NI) were kindly provided by Nancy Cox PhD
World Health Organization Influenza Reference Laboratory at the Centers for Disease
Control and Prevention (Atlanta, GA). Aluck/ennsylvania/1 0218/84 (H5N2),
Aluck/Alberta/35/76 (HINl), and Alew Jersey/8/76 (HswINl) were provided by the
A TCC (Rockvile , MD). Influenza A viruses were propagated in 10-day-old
embryonated chicken eggs. Infected allantoic fluids were harested 2 days after infection
with AlPR/8/34 or NJapan305/57 , and 1 day after infection with A/K/156/97 and
A/K/483/97 , aliquoted, and stored at - C until use. Studies with the A/K/97 virus
strains were performed by John Cru using biosafety laboratory level 3 conditions.
Recombinant vaccinia viruses containing the genes coding for infuenza A viral proteins
, NA, MI , M2 , PBI , PB2 , PA, NS1 , NS2 , and NP were kindly provided by Dr. B.
Moss. They are all derived from the varous infuenza A virus strains which are listed in
Table II-I. They were constrcted and propagated as previously described (Smith et aI.
1987). A recombinant vaccinia virus, which expressed segmented portions of the NP
was kindly provided by Drs. 1. Bennink and L. Eisenlohr.
Table II-I. Recombinant Vaccinia Viruses Used in the Thesis.
Vaccinia Virus Amino Acids Influenza Subtype Construct Donated by
Vac. HA 562 HINI Moss
Vac. NP 498 HINI Moss
Vac. NPI- 168 HINI Bennink and Eisenlohr
Vac. NP2- 147-315 HINI Bennink and Eisenlohr
Vac. NP3- 296-498 HINI Bennink and Eisenlohr
Vac. NSI 237 H3N2 Moss
Vac. NSIA 167 H3N2
Vac. NSIB 139 H3N2
Vac. NSIC H3N2
Vac. NSID H3N2
Vac. NSIE H3N2
Vac. M2 H3N2 Moss
Vac. M 1 252 HINI Moss
Vac. NA 454 HINI Moss
Vac. PBI 757 HINI Moss
Vac. PB2 759 HINI Moss
Vac. PA 716 HINI Moss
he NS 1 clone was given to our laboratory by Robert Lamb. Kamal Saikh made the
trucated NS 1 vaccinia recombinants (Tamura et aI.
, 1998).
B. HUMAN PBMC FOR DERIVATION OF CELL LINES.
PBMC specimens were obtained from normal , healthy, adult donors. All donors were
Caucasian Americans. Most of the donor PBMC had convincing evidence of influenza A
virus specific CTL activity in bulk culture. We concentrated our efforts on the PBMC of
five donors who were available for obtaining repeat samples. PBMC were purified by
Ficoll-Hypaque density gradient centrifugation (Boyam, 1968). Cells were resuspended
at 2 X 10 /ml in RPMI 1640 with 20% FBS (Sigma) and 10% dimethyl sulfoxide and
cryopreserved until use. The HLA alleles of these donors are shown in Table 11-2. HLA
typing was performed in the HLA typing laboratory at the University of Massachusetts
Medical Center.
Table 11-2. Adult Healthy Donors Used for T Cell Line Isolation and y8
T Cell Analysis.
Class I HLA Type Class II HLA Type
Donor DQw
Donor 1 , 11 , 7
Donor 2
Donor 3
Donor 4
Donor 5
C. VOLUNTEER PBMC FOR ISCOM STUDY.
Fifty-five healthy volunteers aged 18-45 years with no known allergy to eggs were
recruited for the study as previously reported (Ennis et aI. , 1999). Volunteers received
one of five study vaccines: (1) standard unadjuvanted influenza virus vaccine (Fluzone),
(2) influenza virus vaccine incorporated into 50 g ofIscoms (Flu-Iscom 50), or (3) into
75 mg ofIscoms (Flu-Iscom 75), (4) influenza virus vaccine mixed with 50 g ofIscoms
(Flu-Iscomatrix 50), or (5) mixed with 75 g ofIscoms (Flu-Iscomatrix 75). The Iscom
formulations were previously described (Ennis et aI. , 1999). PBMC were isolated on
days 0 (prevaccination), 14, and 56 (Ennis et aI. , 1999) according to manufacturer
instructions in the C. (g tubes (Becton Dickinson, Franlin Lakes , NJ). Selection of
the samples of PBMC for testing in ELISPOT assays was based on the volume of
available cryopreserved PBMC , the HLA alleles of the individuals , and the results of
bulk cultue CTL assays performed previously by John Cruz.
Table 11-3. Volunteers from Flu-Iscom Vaccine Study that Were
Analyzed by ELISPOT Assay.
HLA Class I Alleles
Donor # Vaccine Received
Flu-Iscom 75/45
Flu-Iscom 50/45
, 15 Flu-Iscom 75/45
Fluzone Control
Flu-Iscomatrix 75/45
Fluzone Control
Flu-Iscom 75/45
Flu-Iscomatrix 75/45
Fluzone Control
Fluzone Control
Flu-Iscom 50/45
Flu-Iscom 50/45
Flu-Iscom 75/45
D. BULK CULTURES OF PBMC.
Respond PBMC were suspended at 10
/ml in AIM-V medium (Gibco BRL, Grand
Island, NY) containing 10% human AB serum (HuABS) (NABI
, Boca Raton, FL),
penicilin-streptomycin, glutamine, and HEPES in a 70ml flask (Falcon). Stimulators
were infected with the influenza A virus strain 
AlPR/8/34 (HIN1) at an moi of 15 for 1.5
hours at 37 C in 1 ml PBS containing 0.1 
% BSA, and were then added to responders in a
flask at a stimulator:responder ratio of 1: 10. On day 7 of cultue
, cells were restimulated
with gama-irradiated (3 000 rad) autologous PBMC infected with 
AlPR/8/34 at an moi
of 15 for 1.5 hours in 1 ml PBS containing 0.1 % BSA. They were washed twice and
added at a stimulator:responder ratio of 1: lOin fresh medium containing 10% Hu ABS
and 20 U IL-2 (Collaborative Biomedical Products, Bedford MA). Bulk culture
restimulated cells were assayed for cytolytic activity 7 days later.
E. DERIVATION OF CTL LINES.
Influenza specific CTL cell lines were established using a limiting dilution technique, as
previously described (Kurane et aI. , 1989). PBMC which had been stimulated in bulk
culture for 7 or 14 days were collected and plated at a concentration of3, 10, 
or 30 cells
per well in 96-well round-bottom microtiter plates in 1001-1 of AlM-
V medium
containing 10% FBS , 20 U IL- , 1: 1000 dilution of the anti-CD3 monoclonal antibody
(12F6) kindly provided by Johnson Wong, and 10 gama-irradiated allogeneic
PBMC/well. On day 7, 501-1 fresh medium with 10% fetal bovine seru (FBS) 
(Sigma
Immunochemicals , St. Louis, MO) and IL-2 were added, and on day 14 fresh medium
with 10 gama-irradiated allogeneic PBMC/well and 1: 1000 dilution of anti-CD3
monoclonal antibody were added. Growing cells were assayed for cytolytic activity on
days 21 and 28. Cells from wells with influenza A specific cytolytic activity were
expanded to 48-well plates. The two cell lines isolated from the PBMC of donor 3 were
characterized by John Cruz. Some T cell epitopes have been previously defined by
others: NP383-391 (Huetetal. , 1990), MI58-66(Gotchetal. , 1987), NS1122- 130
(Man et aI. , 1995), and MI 17-31 (Rothbard et aI. , 1988). We have identified additional
CD8+ and CD4+ human T cell epitopes (Jameson et aI. , 1998).
F. PREPARATION OF TARGET CELLS.
Autologous lymphoblastoid cell lines (BLCL) were established by culturing with Epstein
Barr Virus (EBV) in 24-well plates as previously described (Green et aI. , 1993). For
target cell usage , BLCL were infected with recombinant vaccinia viruses at an moi of
20:1 for 1.5 hat 37 C. The cells were then diluted in 1 ml of 10% FBS in RPMI 1640
and fuher incubated for 12- 16 h. BLCL infected with influenza A viruses were infected
at an moi of 15:1 in 1 ml of 10% FBS in RPMI 1640 for 12- 16 h. These infected target
cells were labeled with.25 mCi of Cr for 60 min at 37 C. After four washes , the target
cells were counted and diluted to 2xl0 cells/ml for use in the cytotoxicity assay. The
HLA parially-matched allogeneic target cells used in chromium release assays were
BLCL produced in our laboratory from the HLA-typed PBMC of unelated donors, or
were obtained from the National Institutes of General Medical Sciences (NIGMS)
Human Genetic Mutant Cell Repository or the American Society for Histocompatibility
and Immunogenetics (ASHI) Cell Ban and Repository.
G. CHROMIUM RELEASE ASSAYS.
Cytotoxicity assays were performed in 96-well round-bottom plates , as previously
reported (Bukowski et aI. , 1989). Briefly, effector cells in 1 00 l of RPMI 1640 medium
containing 10% FBS were added to 1.5xl03 -2x103 sl Cr- labeled target cells in 100 l at
various effector to target (E:T) ratios. In CTL assays using synthetic peptides , peptides
were added to target cells at the indicated concentrations (. 25 g/ml for screening) and
incubated at 37 C for 30 min, after which the effector cells were added. Several of the
, NSI , and NP peptides were kindly provided by Dr. Arthur Pedzcak and Dr. Pele
Chong (Pasteur Merieux Connaught, Toronto , Canada), and all other peptides were
synthesized at the Core Protein Chemistry Facility directed by Dr. R. Caraway
(University of Massachusetts Medical Center, Worcester, MA). In assays testing the Flu-
Iscom bulk cultues, 1.5x10 K562 cells per well were added to the effectors for two
hours prior and left in durng the assay to reduce natural kiler cell activity. Plates were
centrifuged at 200g for 5 min and incubated for 4-5 hat 37 C. Supernatant fluids were
harested using the supernatant collection system (Skatron Instruents, Sterling,
Virginia), and SICr content was measured in a gama counter. Spontaeous release was
less than 30% in all assays unless otherwise indicated. The percent-specific SICr release
was calculated with the following formula: (cpm experimental release - cpm spontaneous
release)/ (cpm maximum release -cpm spontaneous release) x 100. All assays were
performed in triplicate , and the results were calculated from the average of the triplicate
wells. Specific Immune Lysis (SIL) was calculated by subtracting the percent-specific
lysis of peptide pulsed targets from lysis of uninfected targets.
H. SINGLE CELL ELISPOT ASSAY FOR DETECTION OF IFN- SECRETING
CELLS.
The ELISPOT assay was done as previously described (Lalvani et aI. , 1997). Briefly, 96-
well filtration plates (Milipore, Bedford, MA) were coated with mouse anti-human IFN-
antibody (clone NIB42, Pharingen, San Diego, CA). Cryopreserved PBMC were
thawed, washed and added to the plates at 1. 5xI05 cells per well in RPMI 1640
medium supplemented with 10% FBS , penicilin-streptomycin, glutamine , and HEPES.
Cells were incubated for up to 15 hours with or without peptide (10/lg peptide/ml) or
virus stimulation (virus moi of 15). The plates were washed and then incubated with
biotinylated mouse anti-human IFN-y antibody (clone 4S.B3, Pharingen). Spots were
developed using fresh substrate buffer (.3 mg/ml of3-amino-9-ethyl-carbazole and .015%
in . 1 M sodium acetate (pH 5)). The precursor frequency of specific CTL was
calculated based on the number of spots counted out of the number of cells added to the
wells. Spot forming cells (SFC) were plotted as the number ofSFC per Ixl06 PBMC.
I. INTRACELLULAR IFN-y STAIING.
Two xl06 PBMC were washed two times and stimulated for 4 hours with AlR/8/34
infuenza A virus at an moi of 5 in . 1 mlIO% RPMI/FBS at 37 C. Four hours later
10JlI of Golgi Plug (Pharingen, San Diego , CA) or 10Jlg/ml Brefeldin A (Sigma) was
added to each tube. The cells were washed once and fixed/permeablized with 200JlI
Cytofix/Cytoperm (Pharingen) for 20 minutes at 4 C. Cells were washed twice in
Perm Wash buffer IX (Pharingen) and labeled with 20JlI ofanti-CD4 (SK3 , Becton
Dickinson), anti-CD8 (SKI , Becton Dickinson), or anti-CD56 (BI59 , Pharingen) with
3JlI ofanti-IFN-y (B27 , Pharingen) or control IgGI (MOPC- , Pharingen)
monoclonal antibodies in 50JlI Perm Wash buffer for 1 hour at 4 C. Experiments with 
T cells also utilized y/'6- fitc (#347903 , Pharingen) and V'62 fitc (#33784A
Pharingen). Cells were washed once and analyzed by a flow cytometer. Data was
analyzed by the WinList program (Verity).
J. STATISTICAL ANALYSIS.
For the ELISPOT assay results the Student's t- test was used to compare the significance
of the difference between the varous days assayed. Computer-assisted evaluation was
used to calculate probability values. Values ofp": 0.05 were considered significant.
CHAPTER III
ANALYSIS OF THE T CELL REPERTOIRE IN HUMANS
A. BULK CULTURE RESPONSES TO INFLUENZA A VIRUS AND
CONSTRUCTS EXPRESSING INFLUENZA A VIRAL PROTEINS IN DONOR 1.
We began by analyzing the PBMC of several donors to detect influenza-specific lysis
measured by chromium release assays. We wanted to determine whether individuals
recognized more than one viral protein in bulk cultue and to identify donors whose
PBMC would be of interest for our studies. The PBMC from healthy, adult donors were
isolated and stimulated with PR/8/34 (HINI)-infected autologous stimulators twice (day
o and 7). At day 14 the bulk culture was tested for lysis of autologous B-LCL infected
with infuenza. Uninfected B-LCL were used as a negative control. The bulk cultue
PBMC of donor 1 recognizes targets infected with each of the three subtypes of influenza
A viruses tested (HINI , H2N2 , H3N2) (Fig. III-I). In order to determine which viral
proteins were recognized by the bulk cultue T cells , several vaccinia constructs were
used to infect B-LCL targets. Specific lysis of target cells expressing the infuenza viral
proteins NP , HA, Ml , and NA were detected (Fig. 111-2). The highest lysis was detected
against tagets infected with the vaccinia construct that expresses NP. Similar results
were observed in multiple experiments performed with this donor s PBMC. These
results suggest that donor 1 has influenza-specific memory CTL that recognize multiple
proteins and is cross-reactive with the varous influenza virus subtypes tested.
Fig. 11-1. Donor 1 Bulk Culture CTL Responses
Specific for Influenza A Viruses of Multiple
Subtypes.
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Targets were infected with influenza A viruses at an moi of 15:1. Bulk cultue PBMC
were stimulated with the PR/8/34 virus two times (at days 0 and 7) in vitro prior to the
assay. The negative control was uninfected targets (media only).
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Fig. 11-2. Donor 1 Bulk Culture Responses
Specific for Vaccinia Constructs Expressing
Influenza Viral Proteins.
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Targets were infected with vaccinia virus constrcts at an moi of20. Bulk cultue PBMC
were stimulated with PR/8/34 (HIN1) influenza virus two times (at days 0 and 7) in vitro
prior to the assay and then were tested for lysis of vaccinia virus construct infected B-
LCLs. The negative control was targets infected with a vaccinia virus construct that does
not express an infuenz protein (vac control).
B. BULK CULTURE T CELL RECOGNITION OF INFLUENZA VIRUS AND
VACCINIA CONSTRUCTS EXPRESSING INFLUENZA VIRUS PROTEINS.
To analyze the memory T cell responses to influenza virus by other healthy adult
volunteers , PBMC were stimulated with autologous PR/8/34 infected stimulators on day
o and 7. The bulk cultures were tested in chromium release assays to analyze the specific
lysis of target cells infected with influenza virus or vaccinia constructs. The PBMC of
donor 2 specifically recognized influenz PR/8/34 (HIN1) infected targets as compared
to uninfected targets. This donor also had specific lysis of the Vac NP construct. In
other experiments specific lysis ofVac Ml and PBl targets were also observed (data not
shown).
John Cruz stimulated bulk cultures from donor 3 and observed specific lysis of
influenza infected targets and Vac NS 1 , Vac NP , and Vac M2 infected targets (data not
shown). The bulk cultues from donors 4 and 5 both recognized targets infected with
infuenza PR/8/34 (HINI) as well (Fig.III- B). These donors both exhibited
recognition ofB-LCL infected with the Vac NP construct. Previously, in our laboratory
the PBMC of other donors were tested as well. Overall, most donors had specific lysis at
the bulk cultue level of infuenza infected targets (data not shown). This was expected
because most adults have been infected with influenz multiple times durng their
lifetime. We had identified several donors with memory T cell responses to infuenza
that could be used to characterize the CTL response fuer.
Fig. 11-3. Donor 2 Bulk Culture Responses Specific
for Influenza and Vaccinia Constructs Expressing
Influenza Proteins.
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Targets were infected with influenz virus at an moi of 15 , and with vaccinia virus at an
moi of20. Bulk c\llture PBMC were stimulated with the PR/8/34 virus two times (at
days 0 and 7) in vitro prior to the assay.
Fig. I1-4A. Donor 4 Bulk Culture Responses
Specific for Influenza and NP.
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Fig. I1-4B. Donor 5 Bulk Culture Responses
Specific for Influenza and NP.
virus constructs.
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Targets were infected with influenza virus at an moi of 15 , and with vaccinia virus at an
.. 15
PRl8/34
(H1 N1)
Uninfected Vac NP Vac Control
moi of20. Donor 4 and 5 PBMC were stimulated with PR/8/34 (HINI) twice (at days 0
II 35
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and 7) and tested for lysis ofB-LCLs infected with either infuenz virus or vaccinia
PRl8/34
(H1 N1)
Uninfected Vac NP Vac Control
C. PROTEIN SPECIFICITY OF CTL LINES ISOLATED FROM DONOR 
The bulk culture of influenza A virus-specific CTL from donor 1 were put into 96-well
plates by limiting dilution at 3 , 10 , and 30 cells/well , and wells positive for growth were
screened for lysis of influenza A virus-infected targets. This was done on two more
occasions also. All of the CTL lines were stained for CD4 or CD8 expression by flow
cytometry (data not shown). Ten CTL lines generated from the PBMC of donor 1 were
tested for lysis of targets infected with the recombinant vaccinia viruses and influenza A
virus (PR/8/34, HINI). The results obtained with 6 of the 10 lines are presented in Table
III - 1. These CTL have novel , previously uneported specificities. The other four cell
lines characterized from this donor recognize epitopes that have been previously reported
and wil be sumarized later.
Each of the T -cell lines characterized was specific for one influenza A virus
protein (Table III- I). These cell lines and those with previously reported specificities
recognized NP , PB2 , Ml , HA, PBI , NSI , and NA, making a total of seven different
influenza A virus proteins recognized by the memory T lymphocytes of donor 1. These
data indicate that the CTL responses of this donor to influenza virus are directed against a
I i
broad range of viral proteins and include both CD4+ and CD8+ components.
Table III-I. Identification of Influenza Virus Proteins Recognized by
CTL Lines Generated from the PBMC of Donor 
Virus % Specific )I Cr Release
Strain Used CD8+ CD4+
to Infect Expt. 1 Expt. 2 Expt. 3 Expt. 4
LCL * 10- 1 C4 1O- IB7 2F8 30E 11 1O- IG5 10D9-
PR/8/34
Vac HA
Vac Ml
Vac M2
V ac NS 1
Vac NA
Vac NP
Vac PA
V ac PB 1
Vac PB2
*The E:T ratio was 10:1. Lysis of targets infected with wild-type vaccinia virus was
subtracted from lysis of recombinant vaccinia virus. Lysis of the target cell by the CTL
that demonstrates specific protein recognition defined as greater than 25% specific lysis
is underlined.
D. HLA RESTRICTION OF DONOR 1 CTL LINES.
MHC restriction of the cell lines was determined by using parially HLA-matched
allogeneic B-LCL as targets for CTL lysis. Targets were infected with the recombinant
vaccinia virus that had resulted in specific target cell lysis or with wild-type vaccinia
virus as a negative control. Alternatively, parially HLA-matched target cells were
pulsed with a peptide that contained the CTL epitope. The results in Fig. III-5A show
that targets pulsed with NP peptide containing amino acids (aa) 173- 193 are lysed by
bulk culture effectors if they share HLA B27. When the cell line that recognized that
epitope (l0- IC4) was characterized it was also found to lyse only target cells with B27 in
common when pulsed with the same NP peptide , and it is therefore also B27 restricted
(data not shown). Cell lines 1O- IB7 and 1-2F8 are also able to lyse only targets which
share B27 and are therefore B27 restricted (Fig. 111-5 B and C). Cell line 4-30Ell is
either All , Cw7 , or Cwl restricted, because it does not lyse targets expressing A2 , B27
or B18 (Fig. III-5D). This cell line ceased growing and could not be tested fuher. HA-
specific cell line 10- 1 G5 is B 18 restricted because it lyses targets which have only B 18 in
common (Fig. III -5E).
We also tested CD4+ T-cell line 4- lOD9- , which is DRI restrcted (data not
shown) and another four T -cell lines which recognized previously reported epitopes and
were found to be restrcted by HLA A2.1 , B27, and DRI (data not shown) (Gotch et aI.
1987; Rothbard et aI. , 1988; Huet et aI. , 1990; Man et aI. , 1995). The results shown in
Fig. 111-5 are a representation of the experiments done to confirm MHC restriction of the
CTL lines. MHC restrction of each cell line was confrmed in multiple experiments
using different allogeneic targets. A2. I-restricted lines were confirmed by lysis of
infected Hmy C 1 R A2. transfected targets. Overall , these results indicate that at least
four different class I HLA alleles (A2. , B18 , B27 , and All , Cwl , or Cw7) and one class
II HLA allele (DR!) restrict the CTL lines isolated from donor 1 , and there is not one
influenza A virus-specific dominant HLA allele.
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Legend for Fig. 111-
HLA alleles of parially HLA-matched targets in common with donor 1 are listed on the
Y axis. % specific lysis of negative control vaccinia virus infected targets or uninfected
targets were subtracted from lysis of infected targets. A) Bulk culture lysis ofNP peptide
173- 193 pulsed targets. B) Lysis by cell line 10- IB7 ofvac PB2 infected targets. C)
Lysis bycellline 1-2F8 of vac PB 1 infected targets. D) Lysis by cell line 4- 30E 11 of vac
MI infected targets. E) Lysis by cell line 1O- IG5 ofvac HA infected targets.
E. CHARACTERIZATION OF THE EPITOPES RECOGNIZED BY CTL LINES
FROM DONOR 1.
Recombinant vaccinia viruses that contain overlapping amino acid regions of the NP
gene (see Table II- I) were used to localize the epitope recognized by NP-specific cell line
10- 1 C4. This cell line lysed targets infected with the vaccinia virus construct expressing
NP aa 147 to 315 . We synthesized 20-mer peptides that spaned aa 147 to 315 , and this
cell line lysed targets pulsed with a peptide containing aa 173 to 193. Target cells pulsed
with this peptide were also recognized by effector cells from a 7 -day bulk culture from
this donor (Fig. 111-6). Finer mapping with synthetic peptides indicated that the optimal
epitope is contained within aa 174 to 184 (Fig. III-7A and Fig. III-8A). Precursor
frequency analysis by ELISPOT single-cell IFN-y secretion indicated that this CTL
epitope is recognized by 1 in 4 156 PBMC from donor 1 (Table 111-2).
Peptides containing epitopes that were previously reported were synthesized and
tested for recognition by CTL lines if they shared MHC restrction and viral protein
specificities with the cell lines we isolated. Cell line 10-2C21ysedtargets pulsed with a
peptide representing aa 122- 130 ofNSI , line 1- K lysed targets pulsed with peptide aa
58 to 66 of M 1 , line 1-3 lysed targets pulsed with peptide aa 17 to 31 of M 1 , and line 1-
lysed targets pulsed with peptide aa 383 to 391 ofNP. Precursor analysis of these
epitopes in this donor s PBMC confrmed that these are not rare CTLs generated by the
cloning process (Table 111-2).
Fig. 111-6. Donor 1 Bulk Culture Recognition ofNP 174-184.
100
E:T Ratio
.60:1
030: 1
.15:1
. Donor 1 bulk cultue was stimulated for 7 days with PR/8/34 and tested for recogntion of
virs infected tagets. Peptides were pulsed at a concentration of 25Jlglml, vaccinia
virses were added at an moi of 20, and infuenz virus was added at an moi of 15.
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Table 111-2. Peptide-Specific CTL Frequencies in Donor 1 PBMC as
Determined by ELISPOT.
Precursor Frequency of
Influenza Virus Amino Acids MHC Class I Peptide-Specific IFN-
Protein Restriction spot-forming cells (SFC)
174- 184 B27 1/4 156
58- A2. 1/31 250
383-391 B27 1/16 447
NSI 122- 130 A2.1 .:1/500 000
17- DRI 1/26 316
Negative controls included the addition of no peptide or an irrelevant peptide. Neither
produced SFC in donor 1. The results of this experiment are representative of those
observed in three experiments using this donor s PBMC.
F. DONORS 2 AND 3 ALSO HAVE BROAD CTL REPERTOIRES FOR
INFLUENZA A VIRAL PROTEINS.
After characterizing a broad repertoire of CTL lines that recognize influenza A virus in
donor 1 , we wanted to analyze the PBMC of other donors in a limited way to determine if
they also had broad CTL responses. As before, a bulk cultue was cloned by limiting
dilution to characterize the CTL response at the clonal level. In donor 2 , afer one
limiting dilution, five different cell lines were characterized. They were shown to have
specific lytic activity against four different viral proteins (RA, NP , NA, and MI). Three
CD4+ lines and two CD8+ lines were characterized (Table 111-3). Two of these were NP-
specific , CD8+ 3G 11 and CD4+ 3E5. Recombinant vaccinia viruses expressing
segmented portions ofNP were used to determine the specific region that NP-specific
lines recognize. Cell line 3G 11 lysed targets infected with vaccinia virus NP aa 296 to
498 , and 3E5 lysed tagets infected with vaccinia virus NP aa 147-315. Fine epitope
mapping using synthetic peptides demonstrated that cell line 3E5 recognizes NP aa 255
to 265 at 0. g/ml (Fig. III-6B and III-7B). CD8+ cell lines 3F4 and 3Gll were found
to be B62 restrcted (data not shown) by lysis of parially HLA-matched tagets as
described for donor 1. The restrcting alleles of the thee CD4+ CTL lines were not
determined because they failed to lyse the available parially matched B-LCL tagets.
T cells from donor 3 were also cloned by limiting dilution and two infuenz
virus-specific cell lines were established. Cell line 124 is CD8+ and recognizes M2
while cell line 77 is CD4+ and recognizes NS1 (Table 111-3). A cell line that recognizes
NP was also isolated but not fuer characterized. Synthetic peptides were used to
identify the epitopes. Cell line 124 recognizes aa 7 to 15 ofM2 down to .25Jlg/ml (Fig.
II-6C and III-7C), while cell line 77 recognizes aa 34 to 42 at 25Jlg/ml (Fig. III-6D and
II-7D). HLA restriction analysis was performed by using allogeneic parially HLA-
matched cell lines as done with the two previous donors; CTL line 124 is restricted by
B44 , and CTL line 77 is restricted by DR3 (data not shown)
Table 111-3. Recognition of Influenza Virus Proteins by CTL Lines
Generated from the PBMC of Donors 2 and 3.
% Specific J Cr Release
V irus Infecting Expt. 1 Expt. 2 Expt. 3 Expt. 4
LCL Targets CD8+ CD8+ CD4+ CD4+ CD4+ CD8+ CD4+
3F4 3Gll 3E5 3E9 IOE7 124
PR/8/34
Vac HA
Vac MI
Vac M2
Vac NA
Vac NP
Vac NP (aa 1- 168)
Vac NP (aa 147-315)
Vac NP (aa 296-498)
Vac PA
V ac PB 1
V ac PB2
Vas NS 1
*The E:T ratios were 10: 1. The lysis of tagets infected with wild-type vaccinia virus
was subtracted from the lysis of tagets infected with recombinant vaccinia viruses.
Lines 124 and 77 are isolated from donor 3
, all others are isolated from donor 2. Lysis 
the taget cell demonstrating specific lysis of at least 25% by the cell line is underlined.
G. CROSS-REACTIVE LYSIS BY CTL LINES ISOLATED FROM DONORS 1,
2, AND 3 OF INFLUENZA VIRUS SUBTYPES H1N1, H2N2, H3N2.
It has been previously shown that infuenza virus-specific memory CTL in mice are
either subtype specific or cross-reactive (Effros et aI. , 1977; Zweerink et aI. , 1977;
Zweerink et aI. , 1977; Braciale et aI. , 1981; Kuwano et aI. , 1988). The cell lines were
generated by stimulating PBMC with PR/8/34 (HINI). We infected targets with virus
strains of the three different subtypes (HINI , H2N2 , and H3N2) to analyze the subtype-
cross-reactive natue of the T cell lines. In all donors, most of the cell lines that
recognize epitopes on the internal viral proteins (l0- IC4 , lO- IB7 , 4-30EII , 1-2F8 , 3Gll
lOE7 , 77 , and 3E5) were HIN1 , H2N2 , and H3N2 subtype cross-reactive (Table III-4A).
Cell lines with specificity to the external glycoproteins (lO- IG5 , 4- 10D9- , 3F4 , and
3E9) were either HINI and H2N2 subtype cross-reactive or HINI subtype specific
(Table III-4B). In donor 1 , HA-specific cell line lO- IG5 demonstrated HINI and H2N2-
cross-reactive killng (Table III-4B). Cell line 124 is unque because it recognizes an
epitope on the conserved internal protein M2 and is HINI and H2N2 , but not H3N2
cross-reactive. These results indicate that these donors have both subtype-specific and
cross-reactive CTLs. The cross-reactive CTL recognize targets infected with each of the
infuenz subtypes that have caused pandemics in humans this centu.
Table III-4A. Subtype Cross-Reactive Recognition by Influenza Virus-
Specific CTL from Donors 1, 2, and 
% Specific J1 Cr Release
Cell Line Protein Epitope CD4/ PR/8/34
Japan305/57 Johan33/94
Specificity CD8 HINI H2N2
H3N2
10- 1 C4 174- 184 CD8
10- 1 C4 174- 184 CD8
10- 1 C4 174- 184 CD8
10- IB7 PB2 CD8
10- 1 B 7 PB2 CD8
30Ell CD8
2F8 PBl CD8
2F8 PBl CD8
3Gl1 315-496 CD8
IOE7 CD4
3E5 254-264 CD4
NSI 34- CD4
NSI 34- CD4
- -- -. -' . - -- -
Table III-4B. Subtype-Specific Recognition by Influenza Virus-Specific
CTL from Donors 1, 2, and 3.
% Specific-: Cr Release
Cell Line Protein Epitope CD4/ PR/8/34 Japan305/57 Johan33/94
Specificity CD8 HINI H2N2 H3N2
10- 1 G5 CD8
10- 1 G5 CD8
IOD9- CD4
3F4 CD8
3E9 CD4
124 CD8
*The E:T ratio was 10:1. Lysis ofunnfected tagets was subtracted from that of
infuenz virus-infected tagets. Some cell lines were tested in multiple experiments.
The same experiment may have included more than one cell line. ND
, not tested in that
experiment.
CHAPTER IV
HUMN CD8+ AND CD4+ T LYMPHOCYTE MEMORY TO
INFLUENZA A VIRUSES OF SWINE AND AVIAN SPECIES
A. RECOGNITION OF SWINE AND AVIAN INFLUENZA A VIRUS SPECIES
BY T CELL LINES.
We wanted to determine whether humans have cross-reactive CTL that recognize APCs
infected with infuenz viruses that usually infect the avian or swine population. We
tested the previously characterized cell lines for recognition of tagets infected with avian
or swine strains of influenza. The first influenza virus strain that we tested was AlJ176
(HswlNI), which is a swine-like virus isolated from a soldier who died at Fort Dix
, NJ in
1976 (Webster et aI. , 1992). The human T cell lines characterized in chapter III were
tested for recognition of ta gets infected with ths swine-like virus. The results are shown
in table IV - 1 (Expt. A), and they indicate that about two-thirds of the CD8+ human
infuenz A-specific, subtype cross-reactive CTL lines recognize and kill taget cells
infected with the swine- like AIJ176 virus at levels similar to those for lysis of taget
cells infected with the human PR/8/34 (HINI) virus.
Avian strains that contained either the avian H5 HA
(AIuck/ennsylvana/10218/84 (H5N2)) or the avian NI (AIuck/Albert35176
(HINI)) similar to the H5 and NI proteins of the recently isolated Hong Kong H5NI
viruses were then tested. The results are shown in Table V- I (Expt. B), and they
demonstrate that several of the human serotype cross-reactive CTL lines recognized
autologous tagets infected with the avian viruses to a similar degree as the PR/8/34
human strain. Certain CD8+ and CD4+ T cell lines that recognized epitopes only on HI
or on HI and H2 subtype viruses (e.g. IOD9 or 124) did not recognize the avian virus-
infected cells. A HLA-B27-restricted CD8+ CTL line (1-1) from donor 1 , which is
known to recognize aa 383-391 on NP of the human subtypes HI , H2 , and H3
recognized taget cells infected with the 1976 HINI avian strain (26.5%) but did not
recognize as well tagets infected with the 1984 H5N2 avian virus (8%). There may be a
mutation in ths epitope that decreases the affnity, presentation, or TCR recognition.
Similar results were obtained using another CD8+ CTL line (10-2C2) which is HLA-
A2. 1 restricted and recognizes aa 122-130 on the NSI protein. However, another HLA-
A2. I-restricted line (l- K) specific for MI aa 58-66 recognized target cells infected with
either of these avian viruses to a similar degree as AlR/8/34-infected target cells. To
extend these observations bulk cultue PBMC from donor 1 was stimulated with the
HINI avian strain, and there was specific lysis of tagets pulsed with the NP 383-391 and
Ml 58-66 peptides (data not shown).
Similar results were observed with CTL lines from donors 2 and 3. The CD8+
and CD4+ lines 3011 and 3E5 recognized both virus strains well. However, 3E9 and 77
did not recognize the H5N2 subtype as well as the 1976 HINI virus. These results were
obtained using PBMC of American donors; although the frequency ofHLA alleles vares
considerably between distinct populations groups, some, e. , HLA A2 , represent approx.
30% of both North American Caucasian and Southern Han, the dominant tribe in
southern China (Charon, 1997).
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B. RECOGNITION OF THE 1997 HONG KONG VIRUS STRAINS BY HUMA
T CELL LINES.
The 1997 H5Nl Hong Kong strains were obtained and tested for recognition as virus-
infected autologous tagets by these human T cell lines (Table IV-2). Several of the
donor 1 CD8+ cell lines recognized the H5NI virus-infected target cells, e. , cell line 1-
1 and cell line 1- K. These cell lines recognize epitopes on NP and Ml respectively.
Another interesting cell line, 10- IG5, which was previously shown to recognize HI and
H2 subtypes of infuenza viruses, also recognized both strains of the H5NI subtype. This
cell line recognizes an epitope on the HA which is usually the least conserved viral
protein, but H2 and H5 are the two most homologous HA molecules , thus explaining the
cross-reactive recognition. Cell lines 1-2F8 and 10- IB7 , both HLA-B27 restrcted
recognize epitopes on the PB 1 and PB2 proteins , and recognized target cells infected with
at least one of the 1997 Hong Kong viruses to a similar degree as the earlier human HI
virus. Other CD8+ CTL lines recognized targets infected with HINI virus but not targets
infected with the Hong Kong H5Nl strains , e. , cell line 10-2C2 which recognizes aa
122- 130 on NSI. Another example is the subtype-specific CD4+ CTL line IOD9-dl0
which is HLA-DRI restrcted, NA-specific, and only recognized taget cells infected with
PR/8/34 (HIN1) virus.
Similar results were obtained using cell lines isolated from the PBMC of donor 2.
Entirely cross-reactive killng of tagets infected with the H5NI Hong Kong strains was
observed with one CD8+ CTL line, 3G 11 , which is HLA-B62 restrcted and recognizes
an epitope located withn aa 315-496 on NP. Two CD4+ CTL lines that recognize
epitopes on NP (3E5) and Ml (10E7) also had cross-reactive recognition of the Hong
Kong avian virus-infected tagets. However, 
an NA-specific CD4+ line 3E9 recognizes
only HINI virus-infected target cells. One cell line, 77, from the third donor exhibited a
very cross-reactive pattern oflysis. 
This CD4+ CTL line is restricted by HLA-DR3
recognizes an epitope on aa 34-
42 on the NSI protein. On the other hand, the HLA-
B44-
restricted CD8+ CTL line 124 , which recognizes aa 7-
15 on the M2 protein, killed taget
cells infected with human HINI subtype virus but did not recognize 
taget cells infected
with either of the 1997 Hong Kong viruses.
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C. RECOGNITION OF TARGETS INFECTED WITH AVIAN, SWINE, AND
HUMAN-SPECIES OF INFLUENZA A VIRUSES BY BULK CULTURE PBMC.
Although the previous experiments demonstrate that influenza A-specific CTL isolated
from humans can recognize avian and swine virus strains , we wanted to test the
recognition at the short-term bulk cultue level. PBMC were stimulated with human
PR/8/34 (HIN1) and tested for recognition of targets infected with human HINI 
H2N2 viruses , older avian viruses (H5N2 and HIN1), the recent avian-derived viruses
isolated from humans in Hong Kong (H5Nl), or the swine-like 1976 strain (HswlNI).
The results in Fig. IV - 1 demonstrate convincing killng by cells in these bulk cultues 
tagets infected with the recent Hong Kong viruses (Along Kong/483/97 and Along
Kong/156/97) at least to a degree similar to that of target cells infected with the older
human HINI and H2N2 virus strains (AIR/8/34 and AlJapan305/57). Kiling was also
observed of taget cells infected with the older avian virus strains (AIuck/Albl76 and
Aluck/enn84) and the HswlNI strain (AIJ/1/76). This experiment demonstrates
that humans have memory T lymphocytes that recognize epitopes on avian- and swine-
derived viruses, including the recent Hong Kong-derived strains, in a highly cross-
reactive fashion.
Fig. IV-I. Bulk Culture Recognition of Avian, Swine, Human Viruses.A. AlNJ/1176
AlDucklAlb176
AlDucklPenn/84 .25:1
AlHong Kong/483/97
.50:1
AlHong Kong/156/97
0100: 1
AlJapan/305/57
AlPRl8/34
AlNJ/1/76
AlDuckl AI b/76
AIDucklPenn/84 .25:1
AIHong Kong/483/97
.50:1
AIHong Kong/156/97
0100:1
AIJapan/305/57
AIPRl8/34
100
AINJ/1/76
AIDucklAlbn6
AIDucklPenn/84 012.5:1
AIHong Kong/483/97
.25:1
AIHong Kong/156/97
.50:1
AIJapan/305/57
AIPRl8/34
10 15 20 25 30 35 0/0 Specific Lysis
PBMC from A) donor 1 , B) donor 2 , and C) donor 3 were stimulated with PR/8/34
(HIN1) infected autologous stimulators. Specific lysis ofunnfected control tagets was
subtracted from the infected tagets. 
D. HUMA T CELL LINE RECOGNITION OF MUTATED PEP 
TIDES FROM
THE AlK/97 STRAINS.
The effect of mutations in the 
AlK/156/97 (H5Nl) virus sequence at epitopes
recognized by T cells on the 
AlR/8/34 (HINI) epitope sequence were examined. The
results in Table IV-3 show several mutations and recognition patterns. Cell line 10-
2C2
is CD8+ and recognizes aa 122-130 on the NSI protein ofHIN1
, H2N2, and H3N2
viruses , but it does not recognize target cells pulsed with the 
AlK/156/97 peptide due to
a single N D mutation at aa 127. There is also a M-+I change at aa 129, but this
change in sequence is also found in the 
PR/8/34 (HIN1) strain that this cell line does
recognize. Thus it is the N-+D mutation that abolishes recognition by the 10-
2C2 cell
line. The CD4+ cell line 3E5, which recognizes NP aa 254-
264 ofthe PR/8/34 (HIN1)
strain , also recognized targets pulsed with the AlK/156/97 
peptide despite a T 
mutation at aa 258. A CD8+ CTL line 124, which recognizes an epitope on M2 aa 7-
on the HINI subtype virus, does not recognize the H5Nl peptide which has changes at aa
, 11 , and 14. These results ilustrate that epitopes of avian viruses with conservative 
changes can stil be recognized by human CTL, while those with nonconservative
changes canot.
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E. PRECURSOR FREQUENCY DETECTION BY ELISPOT.
Table IV -4 demonstrates the precursor frequency of CTL detected in the PBMC of donor
1 specific for two epitopes on the human HI N 1 and Hong Kong H5N 1 viruses
determined using the ELISPOT assay for IFN-y secretion. In donor 1 , stimulation of
PBMC with the peptide based on NP aa 174-184 ofPR/8/34 (HINI) had a precursor
frequency of 1/4 348. Stimulation with the NP 174- 184 peptide based on the HK/156/97
strain with a V I change at aa 183 produced a similar number ofIFN-y-secreting cells
(1/5,263). On the other hand, stimulation with a peptide that incorporates the E 
change at aa 23 on the Ml protein of the avian Hong Kong 483 strain resulted in the loss
of detectable IFN-y secreting cells. Thus the quantitative detection of individual peptide-
specific T cells showed either a similar frequency ofIFN-y secreting CTL or an absence
ofIFN-y secreting CTL , depending on the specific epitope and the mutations present in
the recently isolated Hong Kong viruses.
A sumar of the effect of sequence conservation and mutation at CTL epitopes
in the human isolates of avian-derived viruses (AlK/156/97 and AlK/483/97 (H5Nl))
is presented in Table IV-5. Sequence data are available for comparson of seven human
CTL epitopes. Thee epitopes are entirely conserved and are cross-reactive. One CD4+
CTL epitope (M1 17-31) is conserved in AlK/156/97, but not in AlK/483/97. In this
case the E Q change at aa 23 is not recognized by the cell line. There are thee other
epitopes that are not conserved; a B27 -restrcted cell line recognizes a mutation on NP at
aa 183 (V I). The other two epitopes with mutations are not recognized by the cell
lines (NS1 122-130 and M2 7- 15). Therefore, there is cross-reactive recognition by the
human CTL lines of the avian virus strains that are conserved or have conservative aa
changes.
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CHAPTER V
IN VITRO AND IN VIVO 
T CELL RESPONSES TO FLU-ISCOM
VACCINATION
A. IN VITRO CTL LYSIS OF TARGET CELLS PULSED WITH FLU-ISCOM.
We wanted to determine whether Flu-Iscom (inactivated influenz vaccine incorporated
into Iscom paricles) could be presented to influenza specific CTL lines 
in vitro. The
Iscom paricle is thought to be a vehicle for entering antigen into the class I pathway via
endocytosis and entry of antigen into the cytoplasm. A CD8+ HA-specific cell line was
tested for recognition ofB-LCL tagets pulsed with either monovalent formalin-
inactivated, detergent-disrupted AlTexas (HINl) vaccine alone or incorporated into
Iscom paricles. As expected, there was no lysis of targets pulsed with the vaccine alone
(1.4%), but there was specific lysis of target cells pulsed with the Flu-Iscom formulation
(76.6%) (Table V-I). Although the background for both of these targets was high, it did
not increase the specific lysis since the lysis of Alexas vaccine-pulsed tagets was
negative (1.4%). There was also lysis of live virus-infected taget cells, which were
positive controls, and there was no lysis of target cells exposed to Iscomatrx alone
without Flu-vaccine which was the negative control.
Next we tested the abilty of another CD8+ CTL line to lyse tagets pulsed with
an infuenz A viral protein alone or mixed with Iscomatrx. The NS 1 protein was mixed
with Iscomatrix for 24 hours at 4 C before addition to the target cells for another 24
hours. This protein is not in high abundance in the inactivated vaccine preparation, so
this would determine whether any influenza virus protein activates T cells in an Iscom
vaccine. However, this NS 1 protein was mixed with Iscomatrix. The CTL line 10-2C2
recognizes aa 122-130 ofNSI and is cross-reactive to human subtypes of influenza HI
H2, and H3. In Table V-2lysis of taget cells pulsed with the 122-130 peptide was high
(88.4%) which served as a positive control. The negative control with uninfected cells
had no specific lysis. There was also no lysis of target cells exposed to either the NS 
protein alone or Iscomatrix alone, but there was lysis of taget cells exposed to the
mixtue ofNSI protein and Iscomatrx (19.6%). Target cells pulsed with the NSI protein
without Iscoms were not lysed, but this was not due to a failure by the target cells to
present the NS 1 protein, because a CD4+ CTL line specific for another epitope on the
NSI protein lysed the NSI protein-pulsed tagets (data not shown).
Table V-I. Recognition by HLA BlS"Restricted HA-
Specific Human
CDS+ CTL Cell line 
of Alexas HlNl Flu-Iscom Vaccine Pulsed BLCL.
HA-Specific PR/8/34 AlTexas Iscomatrix
AlTexas AlTexas
cell line Virus Virus
V accine Flu-Iscom
Donor 1 33. 1.6
1.4 76.
1 0-2F5
MinIax 12. 12.1 17.4 41.3
44.
*Saponin concentration used was 337. g/m1.
*HA concentration used was 82 
g/m1.
HA concentration used was 57. g/ml; saponin concentration was 337.
g/m1. The
E:T ratio = 10:1.
- - - -
Table V-2. Recognition by Human HLA A2.1 Restricted NSI aa 
122-
130 Specific CD8+ CTL 
Cell line of Recombinant NSI Protein and
Iscomatrix Pulsed BLCL.
Cell line U ninfected NS 1 Protein NSI NS 1 Protein
Iscom -
(aa 122- 130) Protein + Iscom
Donor 1 88.4
19. 11.0
1 0-2C2
MiniMax 17. 19. 17.
29. 21.3
. .
PeptIde used at 25 ng/ml (kIllmg observed down to 0.025 Ilg/ml also).
tprotein used at 35 Ilg/ml.
Saponin used at 100 Ilg/ml.
o Saponin used at 70 mg/ml. The E:T ratio was 10:1.
B. HUMA CTL RESPONSES TO FLU-
ISCOM VACCINES.
In order to determine whether humans would be able to mount a T cell response to
influenza A by vaccination with the Flu-
Iscom vaccines we decided to analyze responses
in vivo. Therefore, a clinical study was performed on 55 healthy adults (ages 18-
years), an CTL assays were performed on ile PBMC 
obtaned from saples of blood
drawn on day 0 (pre-vaccination), 14, and 56 after vaccination with a single
immunization of a formalin-inactivated vaccine:: Iscoms or Iscomatrix. John 
Cru tested
samples of PBMC obtained on days 0, 14, and 56 from each donor together in the same
assay to eliminate varabilty of CTL assays performed on different days. 
In addition, he
included as a positive control in each assay a well-characterized CTL cell line to ensure
that the virus-infected taget cells were suitable for 
detecting specific lysis in the CTL
assay. All assays were performed and 
interpreted under code.
We defined an increase in the post-vaccination sample of2: 10% specific immune
lysis (SIL) above the day 0 level in at least 2/3 E:T ratios was a + + response; an increase
of 2: 5% (a + response) was unformly found to be 
statistically significant. Increases in
the percentage lysis of ..5% were considered negative although some values were 
stil
statistically significant. The CTL data were sent to the clinical monitor who organzed
the results into the vaccine groups. Table V -
3 sumarzes the increases in infuenz A
virus CTL memory detected in the three vaccine groups. The CTL assay results showed
statistically significant (P": 0.01) increases in influenza A-specific CTL memory on days
14 or 56 (5. 37.5% increases) in approximately 50% of the assays performed on
individuas who received one dose of vaccine formulated into Iscoms and in about 30%
BE'
100
of the assays of individuals given vaccine mixed with the Iscomatrix. However
, only 5%
of the CTL assays of the recipients of the standard vaccine had an increase in 
influenz
A-specific CTL memory.
Table V-3. CTL Responders in the Flu-Iscom Phase 1 Trial*
101
Flu-Iscom Flu-Iscomatrix Fluzone
Virus 50/45 75/45 50/45 75/45
(AlTx/36/91)
Nonresponders
10%
)0 10%
Responders
H3 .
(AlJh33/94)
N onresponders
10%
)0 1 
Responders
*Subjects showing from 5-37.5% increases in specific immune lysis in at least two E:T
ratios by the day 14 or day 56 samples above the level of lysis by the day 0 samples.
These experiments were performed by John Cru.
Numerator = dose of Iscomatrx/ denominator = dose of virus HA.
- .
:r 
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C. PEPTIDE SPECIFIC RESPONSES WERE DETECTED IN FLU-
ISCOM
V ACCINE RECIPIENTS.
We studied the PBMC of two HLA-typed vaccine recipients that had received the Flu-
Iscom vaccine. As demonstrated by John 
Cru, the PBMC of these donors had increased
levels of infuenza-specific cytotoxic activity post-vaccinati
. Using the ELISPOT
assay, we examined whether their PBMC post-vaccinati
had increases in the peptide-
specific CTL that secrete IFN-y. Donor 54 had an increase in the precursor 
frequency of
CTL that recognized aa 383-391 of nucleoprotein (NP) on days 14 and 56 (Fig. V-
I B).
This is a HLA-B27 restricted T -lymphocyte epitope, and this donor has the HLA-
B27
allele. Donor 54 also had a modest increase in IFN-
y secreting T cells that recognize an
HLA-A2. 1 resticted epitope aa 58-66 of matrix 1 protein (Ml), but no increases were
detected against a second HLA-B27 restricted epitope NP aa 174-
184 (Fig. V- lA, V- IB).
Therefore , the number of peptide-specific CTL secreting IFN-
y in response to at least
two epitopes that utilze different HLA alleles for 
presentatio were boosted in this
donor. Both of these increases occured by day 14 and 
remained high at day 56 after
vaccine administration. Ths indicates that the number ofIFN-
y secreting CTL specific
for infuenza A virus subtype cross-reactive epitopes were increased up to at least 56 days
post-vaccinati
Donor 8 had a delayed response in which CTL specific for epitopes on 
infuenz
were undetectable on days 0 and 14. However
, by day 56 the number ofIFN-y secreting
cells specific for aa 44-52 on NP increased from undetectable to 1/41
667 (Fig. V- ID).
Ths epitope is HLA-Al restrcted. Likewise, CTL specific for aa 58-
66 on Ml increased
103
from undetectable to 1/53,763 (Fig. V- IC). Neither of these donors ' PBMC had
detectable responses to the control allantoic fluid or to a control peptide derived from
Hantavirus (data not shown). These results indicate that the Flu-Iscom vaccine
augmented the numbers of CTL that recognize epitopes on M 
1 and NP , two internal
conserved viral proteins.
104
Fig. V-I. Peptide-Specific Responses of Two Donors Who
42 56 
Days Post Vaccination
The PBMC from A, B) donor 54 and C, D) donor 8 were stimulated with 
1 O g/ml
of peptide in ELISPOT assays.
Received the Flu-Iscom Vaccine.\_0 --14 --56\
350
300
250
200
150
100
\0 
2 c -8 Ml 58-66\
-+ NP 383-391
-x- NP 174- 184
28 
-+ NP 44-52\
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D. INCREASES IN VIRUS-SPECIFIC IFN-
y SECRETION AND IN VIRUS-
SPECIFIC CTL ACITIVITY.
We next tried to detect changes in the numbers of influenza virus-specific CTL that
secrete IFN-y by using live infuenza virus as a stimulating antigen in ELISPOT 
assays.
Thee general trends in virus-specific CTL secreting IFN-
y were detected. Some vaccine
recipients had very low numbers of precursors specific for influenza virus on days 0 and
, but by day 56 the numbers were significantly increased. The PBMC 
of donor 8
showed this increase; there were no detectable IFN-
y secreting cells that recognized
AlJohan94 on days 0 and 14 , but by day 56 a significant increase in IFN-
y secreting CTL
was detected (Fig. V -2A). Other vaccine recipients had a boost in infuenza-specific
IFN-y secreting CTL in their PBMC above pre-vacci
levels detectable by day 14 after
vaccination. Ths was observed in donor 45, where an increase in the number of IFN-
secreting T cells cross-reactive for both AlJohan94 (H3N2) or AlTexas/91 
(HIN1) was
detected (Fig. V -2B, 3B). Donors 7 and 53 also had a boost in CTL specific for
AlTexas/91 that was sustaned until day 56 (Fig. V-3A, 3C). Donor 53 had a different
type of response to AlJohan94 with an increase in precursor 
frequency on day 14 (Fig.
2C), but by day 56 the number oflFN-y secreting T cells had dropped almost to pre-
vaccine levels.
In most of the vaccine recipients, when there were increases in the number of
IFN-y secreting cells there were also increases in cytotoxic T cell levels of specific lysis
by bulk cultue effector cells that were described previously (Section B). Tables V -
4 and
5 contan both the frequencies oflFN-y secreting T cells and the increases in cytotoxic
: -.
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activity. In general , when the numbers ofIFN-y secreting cells determined by ELISPOT
assay increased, there was also an increase in CTL cytotoxicity. In Table V -
4 the only
time point that did not correlate between increases in the number oflFN-
y secreting cells
and cytotoxic lysis to AlJohan94 was the PBMC of donor 23 on day 56. Although the
number ofIFN-y secreting cells remained high, the CTL lysis did not increase when
compared to day O. Usually the frequency ofT cells that secrete IFN-
y in response to
AlTexas/91 (Table V -5) also increased when cytotoxic activity increased. In donors 7
and 45, however, an increase in IFN-y secreting cells was detected at day 14 without a
corresponding increase in cytotoxicity; but increases in both IFN-y secreting cells and
bulk cultue CTL activity are detectable by day 56. Donor 30 maintaned an increased
IFN-y secreting cells at day 56, but did not exhibit an increase in CTL lysis on that day.
Overall , when there were increases in the levels of bulk cytotoxic activity, the
ELISPOT assay also quantitated increases in IFN-y secreting CTLp specific for
influenz. When differences between the two assayS were observed, changes were
detected by ELISPOT assay, but not by the chromium release assay, suggesting that the
ELISPOT assay may be more sensitive. To be certin that the population of cells that
secrete the IFN-y were T cells, we used intracellular IFN-y staining. Using two-color
FACS we found that approximately 78% of the IFN-y secreting cells were CD8+
, 22%
were CD4+, and less than 1 % were CD56+ cells (data not shown).
Fig. V -2. CTL Responses Specific for AlJohan/33/94.
600
500
400
300
200
100
500
450
400
350
300
250
200
150100 
14 
Days Post Vaccination
Three donors with increases in the numbers of cells secreting IFN-
y in response to
AlJohan33/94. Donor 8 (A) received Flu-Iscom 75/45, donor 45 (B) received Flu-
Iscom
50/45, and donor 53 (C) received Flu-Iscom 50/45. Bars represent ELISPOT # SFC per
lxl0/\6 PBMC, the line represents the % specific lysis previously discussed. The * =
p.:
05 and ** = p.: OI by student t-test. SFC stads for spot forming 
cells.
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Fig. V - CTL Responses Specific for 
Alexas/36/91.
140
120
100
700
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400
300
200
100
700
600
500
400
300
200
100
108
14 
Days Post Vaccination
Three donors with increases in the numbers of cells secreting IFN-
y in response to
AlTexas/31/91. Donor 7 (A), donor 45 (B), and donor 
53 (C) received Flu-Iscom 50/45.
Bars represent ELISPOT # SFC per lxlO/\6 PBMC, the line represents the % specific
lysis previously described. The
'" = p..
03 and ** = p.. 005 by student t-t st. SFC stads
for spot forming cells.
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III
E. FLU ZONE CONTROL VACCINE RECIPIENTS DID NOT HAVE
INCREASES IN THE PRECURSOR FREQUENCY OF INFLUENZA A-
SPECIFIC CTL.
The recipients of the standard vaccine (Fluzone), without being incorporated into
Iscom paricles or being mixed with Iscomatrix, did not 
have increases in bulk culture
CTL activity after immunzation. The PBMC from 3 Fluzone recipients, selected based
on availability of PBMC samples, were tested pre and post vaccination, and there was no
change in the precursor frequency of infuenz A-specific CTL after vaccination (Fig. V-
5 and Table V -6).
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CHAPTER VI
y8 T CELL ACTIVATION IN RESPONSE TO INFLUENZA A
INFECTION IN HUMANS
A. y'6 T CELLS AR ACTIV A TED TO SECRETE IFN-y IN RESPONSE TO
INFLUENZA INFECTION OF HUMAN PBMC.
After determining that humans have a broad CTL repertoire specific for influenza A, we
became interested in the other T cell population called y'6 T lymphocytes. We wanted to
analyze the interactions of infuenz A virus and the y'6 T lymphocytes in the PBMC.
Although y'6 T cells only make up 1- 10% of the PBMC, they are in much higher
proportion in the mucosal areas. These T cells have the ability to secrete cytokines and .' i
lyse cells , and can home to the site of infection (Carding et aI. , 1990; Eichelberger et aI.
1991; Allan et aI. , 1992; Bouller et aI. , 1997; Vincent et aI. , 1998). To observe whether
they could be activated to secrete IFN-y in response to infuenz infection, we used
intracellular IFN-y staning ofPBMC. After the PBMC were infected for 8- 10 hours, the
cells were stained and analyzed by flow cytometr. The T cells were gated on the y'6+
population and the CD8+/CD8-, IFN-y+/IFN-y- cells were analyzed.
The % ofy'6+ T cells in the PBMC of donor I that were IFN-y+ increased from
9% to 9.68% after exposure to PR/8/34 (HINI) virus in vitro (Fig. VI-I). More
noticeable was the CD8- population that increased almost 5 fold. We also found an
115
increase in response to AlJapan57 (H2N2) infuenza virus , but not in response to 
Alort
Chalmers/l/73 (H3N2) influenza virus (data not shown). There seemed to be activated
CD8+ T cells, but the y'6 T cells did not secrete IFN-y in response to this H3N2 subtype
of influenza. In order to determine whether this increase was a donor-specific
phenomenon we analyzed the PBMC of two other donors. Donor 2 had an increase in the
y'6+IFN- y+ population from about 4% in the Ig control to 30% after exposure to PR/8/34
virus (Fig. VI-2). This increase in activated y'6 cells was again most noticeable in the
CD8- population where there was more than a 12-fold increase in IFN-y-secreting 
y'6
cells. Donor 5 had more activated y'6 cells in the PBMC prior to infection; however
, a
clear increase in IFN-y-secreting y'6 cells was apparent (Fig. VI-3). The percent oflFN-
y+y'6+ cells went from about 24% to over 56%. Again, the greatest increase in IFN-
cell was observed in the CD8- y'6 cell population with over a 3 fold increase.
In order to determine whether the virus inf ction was an important factor in this
y'6 T cell activation, PR/8/34 virus was inactivated by boilng and then added to the cells
for the 8- 10 hour incubation. In all three donors, the inactivated virus abolished most
, if
not all, IFN-y secretion by the y'6 cells. Donor 1 maintained a slight increase , but it was
substatially lower than the increase seen after exposure to live influenz virus (Fig VI-
1). Donor 2 had a 3-fold increase with the inactivated virus stimulation, but it did not
reach the 12-fold increase observed with live virus infection (Fig. VI-2). Donor 5 had a
similar percent of activated y'6+ CD8- T cells, with inactivated virus stimulation as with
compared to no stimulation (Fig. VI-3).
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Although the y'6+CD8+ T cells also produce IFN-y upon influenz infection in 
the
three donors tested, it is less clear whether inactivated virus also stimulates these cells. In
donor 1 the inactivated virus stimulated PBMC to a similar degree as the live virus (Fig.
VI- I). However, in donors 2 and 5 there were fewer y'6+CD8+ T cells activated by
inactivated virus as compared to live virus infection (Fig. VI- , VI-2).
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B. TIME COURSE OF INF -y PRODUCTION BY y'6 T 
CELLS AFTER
EXPOSURE TO INFLUENZA VIRUS AND DOSE RESPONSE OF VIRUS
DILUTIONS.
To look at the number oflFN-y secreting y'6 T cells after influenza infection over time,
we added infuenza virus at time 0 and harested the cells at varous time points
thereafter. We analyzed the CD8- population of activated y'6 T cells. 
Around 4-6 hours
post infuenz infection there was a peak in IFN-y secretion in donor 1 10 hours with
the brefeldin A treatment included (Fig. VI-4). Therefore, the CD8-y'6+ T cell population
secretes IFN-y relatively quickly, in the first 10 hours after exposure to 
infuenz virus.
Ths is similar to ap T cells previously found to secrete IFN-y by 6 hours post infection
(Murali-Krshna et aI. , 1998).
Next we analyzed the dose of virus which generated the highest number ofCD8-
IFN-y secreting y'6 T cells. At a 1: 11 dilution of virus (approximately an moi of 8), the
peak IFN-y response occured, while fuer dilutioris produced decreasing numbers of
IFN-y secreting cells (Fig. VI-5). Both the 8-10 hour total time point and the 1 :11
dilution of virus Were used in the subsequent experiments.
""-.:- . ._. .
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Fig VI-4. Time Course of IFN-y productio by CD8-
y8+ cells in the
PBMC of Donor 1.
rI 
t) 3
u .-
"C ..
t) 
.. 04
S: .
C. "C
.= .c
donor 1 \
The hours indicated on the X axis are the number of hours prior to the addition of
brefeldin A for 4 hours. The 
y'6+ CD8- population was gated.
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Fig IV -5. Dose Response of Influenza Virus Infection 
of PBMC.
I = QO 0Q .-U :;
+ = 
"0 
- 0
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:s 1
 y
18Donor 1 
moi of influenza virus
Virus was diluted and added to PBMC for 8- 10 hours. The 
y'6+ CD8- population was
gated.
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C. EXPRESSION OF ACTIVATION MARS ON y'6 T CELLS IN RESPONSE
TO INFLUENZA INFECTION.
In order to determine whether y'6 T cells increase the surace expression of T cell
activation markers in response to infuenz virus , expression of CD69 and CD25 were
analyzed. CD69 and CD25 are early activation markers expressed on ap T cells. y'6 T
cells have been shown to express CD25 and CD69 also (Moretta et aI. , 1991; Wallace et
1..
al. , 1995). PBMC were stimulated with infuenz virus for a total of 8- 10 hours and two-
color flow cytometry was performed. In donor 1 there was a large increase in CD69
expression of y'6 T cells in response to infuenz virus. The percent of y'6+ T cells
expressing high levels of CD69 went up almost 85%, and the mean level of florescence
increased (Fig. VI-6).
To fuher analyze the type ofy'6 T cell that is upregulating CD69 , we used three-
color flow cytometry to distinguish between the CD8+ and the CD8- populations of y'6 T
cells. In donor 1 there was an increase in the percent of both CD8+ and CD8- CD69+ y'6
T cells. The CD8+ CD69+ T cells increased from approximately 52% in unnfected to
88% in the PR/8/34 infected cells. Ths percentage was 86% of the CD8+ y'6 T cells
exposed to the inactivated virus. The CD8- population is about thee times the size as the
CD8+ population, and it also had an increase in surace CD69 expression in response to
PR/8/34. The CD8-y'6+ cells went from 40% CD69 expression positive in the unnfected
population to 92% in the infuenz infected cells. There was a slight decrease in the
percentage of cells expressing CD69 (10%) when stimulated with inactivated virus. The
124
data on CD69 expression were not as different between live and inactivated virus 
in this
donor.
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Fig. VI-6. CD69 Expression on y8 T Cells Infected with PRl8/34 (HtNt)
in Donor 1.
. .
Ig Control
36.64%
PRl8/34 Virus
84.97%
FL2-He -
Uninfected
63.58%
FL2-He -
PBMC was y'6+ gated, and CD69 expression assessed. Between 450 and 700 events were
FL2-He -
CD69
plotted as histograms.
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CD25 expression was analyzed in the PBMC of donor 5. The y'6 population in
this donor is comprised of approximately 15% CD8+ and 85% CD8- T cells. Therefore
more cells could be analyzed with the CD8- phenotype. Similar results as with the CD69
surface expression were observed. First of all , the CD8+ and CD8- y'6+ T cells increased
CD25 surface expression in response to influenza infection (from 5% to 41 % for CD8+;
from 1.6% to 32% for CD8-) (fig. VI-8). For both cell types the inactivated virus did not
stimulate a CD25 high population, but did stimulate some increased CD25 expression on
y'6 cells.
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D. DETERMINATION OF WHETHER IFN-y SECRETION BY 
y'6 T CELLS CAN
BE INHIBITED BY ANTI-CLASS I MONOCLONAL ANTIBODIES.
Some groups have found that y'6 T cells are restrcted by MHC alleles
, but, most groups
have found that y'6 T cells are non-MHC restrcted. To determine whether the activation
is MHC restricted we incorporated an anti-class I mAb into the intracellular IFN-
staining assay. Antibody was added prior to the addition of infuenza virus or inactivated
virus paricles. No inhbition was found for the CD8- y'6+ T cell population (Fig. VI-9).
There were comparable numbers oflFN-y secreting cells with or without the antibody
(3.9%). However, the CD8+ y'6+ T cells were inhbited by the antibody by greater than
50% (from 23% down to 9.2%). To be sure that the antibody was added at the proper
concentration, we analyzed the CD8+ population as a whole and observed an inhibition in
IFN-y secretion upon addition of the antibody (data not shown). This indicates that some
CD8+ y'6+ T cells may use the MHC class I molecule to become activated. However
, the
CD8- y'6+ T cells become activated to secrete IFN-y by a different means.
r"
'
"
"
"
"
'
I I
I
Fi
g.
 V
I-9
. A
nt
i-C
la
ss
 I
 A
nt
ib
od
y 
In
hi
bi
ts
 C
D8
+ 
y
8+
 T
 
Ce
ll 
IF
N
-y 
Se
cr
et
io
n,
 B
ut
 N
ot
 C
D8
- 
y
8+
 T
 
Ce
lls
.
U
ni
nf
ec
te
d
P
R
l8
 V
ir
us
PR
l8
 In
fe
ct
ed
 +
m
A
b 
to
 C
la
ss
 I
J:
 -
"
"
.
80
%
24
.7
7%
23
.1
7%
24
.2
9%
20
%
.
.
: 
:
:
'
 
I
!
.
 
'
:
.
.
 
..
 
.
''
;:'
.
 
"
1:
i"
.
 
.
:
.
 
j,
~
~
~
.
 
:.
"
 
"
-
,
.
::
,.
.' 
,
.
.
,
.
 
.
)/:
::
:.
.'
,
;' 
J:
 -
"
"
 
.
J:
 -
"
"
 
.
91
%
90
%
.
35
%
Fl
2-
H
 
-
FL
2-
H
 
-
FL
2
H
 
-
-
=
-
.-
-
=
j
IF
N
-
Th
e 
y'
6+
 
ly
m
ph
oc
yt
es
 w
er
e 
ga
te
d.
 T
he
re
 w
er
e 
18
00
 e
ve
nt
s p
lo
tte
d 
on
 th
e 
hi
sto
gr
am
s. 
Th
e 
m
A
b 
w
as
 u
se
d 
at
 a
 d
ilu
tio
n 
of
1:
 1
 0
00
 fo
r 3
0 
m
in
ut
es
 p
rio
r t
o 
ad
di
tio
n 
of
 v
iru
s t
o 
th
e 
PB
M
C 
of
 d
on
or
 1
.
.
 
.
1,) 1
E. VACCINIA VIRUS DOES NOT ACTIV ATE y'6+ CELLS IN PBMC AS WELL
AS INFLUENZA.
To determine whether any virus would give us similar results
, we infected PBMC with
vaccinia virus (3xl08 PFU/ml) instead of influenza virus. Although there was the
characteristic increase in y'6+CD8- cells that produce IFN-
y in response to infuenza
infection, there was no increase detected with vaccinia virus infection (Fig. VI-
I0).
There was some activation of the y'6+CD8+ cells (.65%) but it did not reach the amount
detected with infuenza infection (4.40%). To be certain that the vaccinia virus was live
and at a high enough titer, we analyzed the entire CD8+ T cell population in the PBMC
and found that approximately 3% of the CD8+ T cells (probably aP) in the lymphocyte
population responded to vaccinia virus as compared to the .59% by unnfected cells (data
not shown).
Fig. IV-lO. Donor 1 y/8 T Cells Do Not Respond to Vaccinia Virus.
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The y'6+ lymphocytes were gated. There were 2500 events plotted on the histograms.
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CHAPTER VII
DISCUSSION
A. THE HUMA CYTOTOXIC T CELL REPERTOIRE SPECIFIC FOR
INFLUENZA A VIRUS.
The infuenza virus-specific T-cell repertoire 
was analyzed in healthy adults from the
United States. The PBMC of five donors 
recognized influenz-infected targets when
stimulated by PR/8/34 (HIN1) in bulk cultues. 
Previously, it was reported that humans
have bulk cultue CTL responses to tagets expressing 
NP, Ml, and PB2 infuenza viral
protein (Gotch et aI., 1987). We found tht NP expssing taget
were recognzed by
all donors, PB 1- and HA- expressing 
tagets were lysed by the PBMC of donor 1, and
NS1-expressing tagets were lysed by the PBMC of donors 2 
and 3 in bulk cultue. Since
infuenza A virus-stimulated bulk cultues recognized 
multiple infuenza A virus
proteins, we decided to analyze the CTL at the clonal level to determine whether humans
have a multi specific CTL memory response specific for 
infuenz A virus.
Previously, in the murne system, the CTL 
repertoire specifi for infuenz A was
found to be limited (Pala and Askonas, 1986; 
Bennnk and Yewdell, 1988; Vitiello et aI.,
1996). For example, tagets infected with vaccinia virus 
constructs that express NP were
lyse by bul cultue CTL ftm viru-
immune mice wiil eiiler ile K or K' allele in
common, but not by mice with only the D
, D , or L d alleles in common. Furermore,
tagets inecte wiil vacinia viru constrcts expressing 
PB2 we only lysed by CTL
""=-- - '.. ' . ,.. ' ' . , ",y-
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from mice with the D allele (Bennink and Yewdell , 1988). This indicated that only mice
with certain MHC alleles would recognize epitope(s) on a certin viral 
protein. After that
initial finding, many groups have reported immunodominant epitopes on 
infuenz viral
proteins (e.g. NP 366-374 in H- mice; NP 147-155 in H- mice).
Nonimmunodominant epitopes have been reported in the H-
mouse; the CTL specific
for these epitopes were detected after several peptide immunzations and were not
observed in mice after infection with virus (Ouka et aI., 1994; Ouka et aI. , 1996).
However, mice immunized with both the immunodominant peptide and the sub 
dominant
peptide were protected better against influenza challenge than immunization with the
immunodominant epitope alone (Ouka et aI. , 1996). This suggests that mice mount only
a limited CTL response to infuenz A, and it may be beneficial to have a broad
multispecific CTL response.
Human CTL that recognize infuenz A virus-infected targets have been reported,
but most groups have only focused on a single HLA allele (such as A2. 1) or viral protein
(such as NP), and the CTL were not usually isolated from the same donor (McMichael et
aI. , 1986; Gotch et aI., 1987; Huet et aI., 1990; Cerudolo et aI. , 1991; DiBrino et aI.
1993; Sutton et aI. ; 1993; Man et aI. , 1995). There has been one report of multiple NP
epitopes found in one individual specific for the much more conserved 
infuenz B virus
(Robbins et aI., 1997). However, there have been few reports on the breadth of the
memory response to infuenz A and recognition of the other 9 viral proteins in addition
to NP. The previously identified CTL specific for infuenz A are 
sumarzed in Table
3. Human CTL epitopes have been more thoroughly characterized in other systems
: .
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such as the HIV system; however
, most of the HIV- l epitopes were also identified in
different individuals (Johnso and Walker, 1994). Moreover
, HIV is a persistent viral
infection and may have a different type of CTL repertoire than an acute self-
limited
infection with infuenz would 
induce.
Many infuenz A virus-specific CTL lines were isolated from three donors we
studied in detail (Table VII- I). We isolated both CD4+ and CD8+ CTL from each donor.
In donor 1 , there were 10 CTL lines characterized. 
These CTL recognized seven
different viral proteins: NP, NS1, HA, PBl, PB2, 
Ml and NA. This proves that there is a
broad pattern of infuenza A virus recognition by the 
CTL from this donor reflected in the
number of viral proteins recognized. Isolated from this donor were even more CTL lines
which were not characterized in such detail, but also reflected this very broad CD8/CD4
CTL recognition of multiple influenz A virus 
proteins (data not shown). This is the first
report of human CD8+ CTL lines that recognize epitopes on the PB2 and HA proteins of
infuenz A virus. From donor 2, five 
cell lines were characterized. These CTL lines
recognized four different viral proteins: HA, NP, NA, and Ml (Table VII-
I). Two cell
lines were characterized from donor 3, specific for NS 
1 and M2 (Table VII -1). This is
the first characterization of a human CD8+ CTL line specific for an epitope on M2, and a
CD4+ CTL line specific for NS 1. Our results suggest that humans have a broad
multispecific response with no single immunodominant epitope, unlike what has been
reported in the murne system for infuenz and 
other viral diseases (such as LCMV)
(Van B1eek an Nailenson, 1990; Vitiello et aI.
, 1996; Hudsier et aI., 1997). Due to ile
i -
marked antigenic varation of influenza A viruses
, a polyclonal response 
to several
epitopes may be beneficial to help clear virus and decrease morbidity.
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Table VII-I. Summary of eTL Liues 
Isolated from All Three Douors.
CTL CD4/ Influenza
Subtype Specifi Localization
HLA
Line CD8 Protein
or Cross-reactive of Epitope
Restricting
Recognized
Allele
Donor 
10- 1 C4 CD8
Cross-reactive 174- 184
B27
10- 1 B 7 CD8 PB2
Cross-reactive
B27
30El1 CD8
Cross-reactive
All1Cwl
10- 1 G5 CD8
HI, H2 Specific
B18
2F8 CD8 PBl
Cross-reactive
B27
10D9- CD4
HI Specific
DRI
10-2C2 CD8 NSI
Cross-reactive 122- 130*
A2.l
CD8 Cross-reactive
58-66* A2.l
CD4 Cross-reactive
17-31 * DRI
CD8 Cross-reactive
383-391 * B27
Donor 
3F4 CD8
HI Specific
B62
3Gl1 CD8
Cross-reactive 315-496
B62
3E9 CD4
HI Specifi
10E7 CD4
Cross-reactive
3E5 CD4
Cross-reactive 254-264
Donor 
124 CDS
HI Specific
B44
CD4 NSI Cross-reactive
34- DR3
Dash mdicates that the epitope was not localIzed or the HLA 
restrction was not
determined. A * indicates that ths epitope was 
previously reported.
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There were a varety of different HLA alleles utilzed by the CTL isolated from
these donors (Table VII- I). In donor 1 CTL lines were restricted by A2.
, B27 , B18 , and
DR1. CTL lines from donor 2 were restricted by B62 and an unidentified class II allele
while the CTL lines from donor 3 were restricted by B44 and DR3. Furhennore
, HLA
alleles were able to present more than one epitope 
withn an individual. For example,
there were HLA B27-restricted epitopes on PB1 , PB2
, and NP in donor 1. This donor
also presented epitopes from MI and NSI on HLA A2.
1. Similarly the CTL lines from
donor 2 recognized epitopes on NP and HA that were both presented on B62.
To detennine whether the CTL lines that we isolated were rare cell lines in the
PBMC of the donors, we used an ELISPOT assay to count the number oflFN-
y secreting
CTL in the PBMC. The ELISPOT assay measures single-cell IFN-
y secretion by PBMC
stimulated with a peptide. This method has been used by several groups to detect
infuenz specific precursor CTL in humans (Lalvan et aI. , 1997) and LCMV -specific
precursor CTL in mice (Murali-Krshna et aI. , 1998). We detected the highest number of
CTL precursors directed at the NP 174-184 epitope, with a frequency of 1 in 4
156.
However, aa 58-66 ofMl, aa 17-31 ofMl , and aa 383-391 ofNP had precursor
frequencies of 1 in 31 250 , 1 in 26 316, and 1 in 16 447 respectively indicating that they
are not rare CTL. These memory CTL precursor frequencies specific for 
infuenza A are
similar to those previously reported in other donors (Lalvani et aI. , 1997).
Subtype cross-reactive and subtype specific CD8+ CTL have been isolated from
mice (Bennnk et aI., 1982; Braciale et aI., 1986; Kuwano et aI. , 1990) and subtype cross-
reactive CD8+ CTL have been isolated from humans (McMichael et aI., 1986).
-- .
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Furermore in humans, subtype cross-reactive and subtype-specifi
lymphocyte
proliferation was previously reported (Lamb et aI., 1982). All of the CTL lines that we
characterized were HIN1 , H2N2, and H3N2 subtype cross-reactive ifthey recognized
epitopes on the internal conserved proteins of influenza such as NP, NS1
, PB1 , PB2 and
MI. Having memory CTL that recognize the internal conserved proteins of 
infuenza
may help clear virus rapidly when another subtype of virus infects. The CTL lines that
recognized the external glycoproteins HA and NA were either subtype specific (only
recognize HIN1) or parially cross-reactive (recogniz
HINI and H2N2). The HI and
H2 hemagglutinins are closer in homology than the HI and H3 glycoprotei
. An HI-
cross-reactive CD8+ epitope in H- mice was detected on the HA transmembrane region
by our laboratory (Kuwano et aI., 1988) and CD4+ HA and NA subtype specific CTL
have been previously identified in humans (Sterkers et aI., 1985), but this is the first
report of HA subtype-specifi human CD8+ CTL.
We isolated and characterized six CD4+ CTL lines. The role 
ofCD4+ CTL in
virus infections, including influenz, is not 
as well defined as CD8+ CTL. p2-
micro globulin-deficient mice have delayed viral clearance and increased 
mortlity after a
virulent infuenz A virus infection (Bender et aI., 1992). However
, these mice can
surive infection with a less virulent infuenz A 
virus and can eliminate virus from the
respiratory tract, whereas infection of nude mice or mice treated with antibodies to both
CD4 and CD8 eventully leads to death (Eichelberger et aI., 1991). These results lead us
to speculate that CD4+ CTL can help compensate for the loss of CD8+ CTL 
durng a
viral inection. Durng acute LCMV infection the CD4+ T helper splenic populatio
.-.;
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increases up to 1 in 600 splenocytes, and remains as long-
lived memory at a precursor
frequency of 1 in 1200 (Varga and Welsh, 1998). We were able to also characterize the
memory CD4+ precursor frequency specific for Ml 17-
31 of influenza A. The precursor
frequency of these CD4+ CTL was 1 in 26,
316 PBMC, which is higher than the well
characterized Ml 58-66 CD8+ A2.l-restricted epitope in the same donor. These results
add to the growing evidence that CD4+ CTL are stable into long-
term memory.
Healthy adults have probably had more than one exposure to 
influenz A because
primar infections generally occur durng childhood (Glezen, 1980). The 
primar
infection in a nonimmune host would result in extensive virus replication and would be
expected to stimulate the infuenz A virus-specific naive T cell repertoire. Secondar
and subsequent infuenza A virus infections would 
stimulate memory CTL which
recognize epitopes on conserved proteins.
It is of interest that several novel T cell epitopes were defined. 
For example , cell
line 10-1 C4 from donor 1 recognizes aa 174-
184 of NP , line 3 E5 from donor 2
recognizes aa 256-266 ofNP, line 77 from donor 
3 recognizes aa 34-42 ofNS1, and line
124 from donor 3 recognizes aa 7-15 ofM2. We 
described a broad CTL repertoire that
may benefit humans, who are one of the natual hosts for 
these antigenic ally highly
varable viruses. In addition, our results suggest that many of the 
infuenza virus
strctual and nonstrctual proteip.s contain epitopes that may be useful to consider in
vaccine development. It would be desirable to augment 
cross-reactive memory CTL to
provide a second line of defense against infuenza disease, especially where major
antigenic varation occurs at the antibody binding sites of 
HA. Overall, these results
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Suggest that unike the experimental 
models in inbred mice, humans have a broad
repertoire of CTL that respond to influenz A.
B. HETEROSUBTYPIC IMMUNITY TO INFLUENZA A 
VIRUSES IN
HUMAS.
We have demonstrated that adults living in the United States have 
influenz A-specific
CD8+ and CD4+ memory T cells that recognize epitopes on 
infuenza A virus strains
derived from swine and avian species including the 1997 H5Nl virus strains isolated
from patients in Hong Kong. This is the first report that characterizes the human CD8+
and CD4+ CTL responses to influenz A viruses 
of nonhuman species. The results
clearly show that adult humans with no known exposure to swine or avian 
infuenz A
virus strains possess high levels of memory CTL capable of lysing swine or avian
infuenz virus infected tagets at the bulk cultue level following stimulation with 
HINI human subtype infuenza A virus. Recognition by bulk cultue T cells of
autologous taget cells infected with the recent Hong Kong HSNI isolates was similar to
the level of lysis of tagets infected with human infuenz A 
viruses. These bulk cultue
results were in accord with the specific CTL lysis of 
taget cells infected with the swine
and avian-derived virus strains and the recent HSN 
1 isolates from Hong Kong by a panel
of human CD8+ and CD4+ CTL lines, the majority of which are cross-reactive among
the HI , H2, and H3 subtypes.
The cross-reactive recognition by the panel of human CD4+ and CD8+ CTL lines
agrees with available sequence data. Epitopes on the swine-
derived HswlNl , the older
c="
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avian virus H5N2 and HINI strains, and the recent H5NI isolates from Hong Kong with
no mutations or few conservative aa changes were recognized by the CTL lines. 
For
example , the T -I change in the AlK/156/97 strain at position 4 of the epitope
recognized by the CD4+ CTL line 3E5 did not abrogate recognition. This aa change does
not result in a different charge at that aa, however there is a loss of polarity. 
T cell lines
failed to recognize other strains when certain nonconservative mutations occured. 
For
example, a N-D mutation at position 6 of the epitope on NSI in the AlK/156/97 
strain
abolishes recognition by cell line 10-2C2. Therefore, having an acidic 
aa at this position
that is usually oriented toward the cleft top (Engelhard et aI., 1993) abrogates recognition
by this cell line. It is interesting that other avian viruses such as 
Alucklkraine/1/63
also have ths mutation at aa 127 ofNS 1 (Man et aI., 1995). Mutations that occur at CTL
epitopes have the potential to lose MHC binding, become a 
parial agonist, or lose TCR
recognition (competitive inhbitor). Mutations that cause an epitope to become a 
parial
agonist has been observed in other systems including dengue virus infection (Zivny et aI.
1999). However, we have not yet distinguished between these possibilties with the
AlK/97 virus epitopes.
The estimation of precursor frequency in PBMC using the IFN-
y ELISPOT assay
was in accord with the results of the CTL assays performed with bulk 
cultues and with
the T cell lines. Cross-reactive CTL which killed tagets infected with human 
and avian
species of infuenz virus were detectable at the single cell level in PBMC at similar
precursor frequencies following stimulation with either the human HINI 
peptide or the
corresponding avian H5NI peptide. Ths was observed with peptides based on the NP
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epitope with aa 174- 184 , which has a conservative V I change in the 
AlK/156/97
strain and has a precursor frequency similar to that detected with the 
AlR/8/34
sequence. On the other hand, peptides of the H5N 1 virus with mutations in the epitope
that resulted in no lysis of virus-infected or peptide-pulsed target cells had an
undetectable number oflFN-y secreting cells following stimulation with the H5Nl
peptide. For example, the E Q mutation at position 7 in the Ml epitope (aa 17-31)
abrogated IFN-y secretion. The number of SFC derived using the human HINI 
viral
peptide stimulation was much higher than that of the AlK/483/97 peptide. Therefore
replacing the acidic glutamic acid residue with the neutral glutaine residue at position 7
on this epitope decreased IFN-y secretion by the PBMC of donor 1. It has previously
been reported that changing this aa to an asparagine, along with a tyrosine at position 3
and a lysine at position 10 abrogates proliferation of T cell clones (Rothbard et aI. , 1988).
The role of cross-reactive memory T cells durng infection with nonhuman
infuenz A viruses is not well understood. There was relatively little influenz A virus
activity in the two decades prior to the 1918 infuenza pandemic (Collns, 
1957). An
epidemic occured in 1890 which seems to have been caused by a H3-like virus based on
serological evidence in individuals born before 1890 (Masurel and Marne, 1973). The
causes of the tremendous mortlity durng the 1918 pandemic are not known. Young
adults, especially ages 25-35 years old, had very high mortlity rates durng the 
1918
pandemic which is unusual in infuenza; deaths usualy occur in the very young and in
older individuals (Collns, 1957). Thus, a VV-shaped cure in age-related mortity with
the peak deaths between the ages of25-35 was described instead of the usua U-shaped
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cure with deaths peaking only in the very young and old (Collns, 1957). 
In addition to
the unusual virulence of the 1918 influenza A virus, memory responses, including cross-
reative influenz-speific T cell 
responss, may have been low or absent in 
some of ile
young adult cohort beause ilere was relatively litte 
inuen A activity noted durng
the two decades immediately before 1918 (Collns, 1957).
The impact of cross-reactive T cells durng influenza epidemi
and pandemi
unown. In 1957, most adults presumably had cross-reactive CTL memory to epitopes
on the HINI viruses , which circulated widely before the H2N2 pandemi
of 1957.
Similarly, when the H3N2 "Hong Kong
" virus emerged in 1968, adults and older
children would be expected to have had cross-reactive memory CTL as a result of
inection with the prior H2N2 virus strains, and adults would also have been exposed to
the earlier HINI strains. The pandemic of 1957 caused more deaths than that of 1968,
but fortunately this was only a fraction of the deaths that were observed in 1918.
Although it is clear that cross-reactive memory T cells did not prevent infections and
excess mortality in 1957 and 1968, these memory T lymphocytes may have contributed a
degree of parial protectio
by limiting the degree of viral replicatio
, based on
experimental studies ofCTL in mouse models (Wells et at, 1981; Taylor and 
Askonas,
1986; Kuwano et at, 1988; Kuwano et al., 
1990).
Our results suggest that adults living in urban areas have CD8+ and CD4+
memory CTL as a result of prior infection with human 
infuenz A viruses, and these
CTL are in large par cross-reactive 
to epitopes on infuenz A virus strains derived from
swine and avian species. Although we detected mutations at 
several human CTL
-:..
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epitopes, some mutat virus sequences were stil recognized by these cell lines. Most of
the human CTL cell lines were able to recognize entirely conserved or mutated viruses
consistent with the results of our bulk cultue experiments. There is considerable
conservation among the genes encoding the internal and nonstructual proteins of
infuenza A virus, which may explain our results. The presence of these memory T
lymphQcytes may playa role in helping to restrict virus replication, thereby decreasing
morbidity and mortality to a degree. Our results support the hypothesis that cross-
reactive T cells wil be activated in humans by infection with a novel 
infuenz A virus
derived from another species, and the activation of these memory CTL by infection may
result in reduced replication of the new infecting virus.
C. FLU-ISCOM VACCINES INCREASE CTL MEMORY IN VACCINATED
HUMAS.
Our results verify that protein antigens can be formulated with Iscom paricles to be
presented by HLA class I molecules and be recognized by CD8+ and CD4+ CTL in vitro.
These results extend earlier findings that demonstrate murne CD8+ T cell recognition of
epitopes on proteins that entered cells treated with osmotic shock or formulated into
paricles (Schild et aI. , 1991). In these experiments we show that formalin-killed
monovalent infuenz A virus vac ine formulated into Iscom paricles enabled the
mixtue to be recognized by a HA specific CD8+ CTL line. Furermore, we were able
to mix a recombinant NS 1 protein with Iscomatrx and detect recognition of pulsed
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tagets by a human CD8+ CTL cell line
, while the recombinant protein alone was not
recognized.
Along with the in vitro data, in vivo work done by John 
Cru in our laboratory,
showed that the Iscom adjuvanted influenza vaccines increased influenza A virus CTL
memory activity in humans after a single dose (Ennis et aI., 1999). The increases were
detected first by bulk cultue CTL lysis of 
infuenz infected target cells. The increases
in cytolytic activity post vaccination were most apparent in the recipients of the Iscom-
formulated vaccines, with a smaller number of individuals responding well to the vaccine
mixed with Iscomatrx. Virtally no 
increases in bulk cultue CTL activity were detected
in the recipients of the infuenza vaccine 
alone.
This led us to examine the precursor frequency of CTL pre and post vaccination
with either the Iscom vaccine or the influenza vaccine alone. We observed increases in
peptide-specifi T cells secreting IFN-y in the PBMC of several vaccine recipients
indicating that a single dose of a Flu-Iscom vaccine was capable of boosting the numbers
of infuenz A virus-specific memory T cells. This expands upon previous work in the
mouse where Iscom vaccines were shown to boost peptide-specifi
cytotoxicity in the
BAL in chromium release assays (Sambhara et aI.
, 1998). The murne CTL recognized
aa 189-199 on HA2, which is conserved between HI N 
1 and H2N2 subtypes, but not the
H3N2 subtype. The mice did not have an increase in CTL lysis to an immunodominant
NP epitope (NP 147-158) that is usualy induced durng live infection. However, 
mice
that received a DNA vaccine containing 
ths epitope had an increase in 
CTLp frequency
by limiting dilution assay (LDA) that correlated with the extent of protectio
against
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challenge (Fu et at, 1999). In 
humans we identified increases in the precursor frequency
ofCTL that recognize epitopes on the Ml and NP proteins of 
influenz virus. Our
laboratory has shown that these virus-specific CTL are able to be activated to lyse
infected cells, proliferate, and secrete IFN-
y. Although in humans we canot determine
whether the precursor frequency of these influenza-specific CTL is high enough to
provide protectio against ilness, mice with CTLp frequency of
1/100,000 spleen cells
to NP aa 147-158 were protected after receiving a DNA vaccine (Fu et at, 1999).
Three types of changes in the number ofIFN-
y secreting cells in the vaccine
recipients ' were detected. Some donors had undetectable numbers of 
infuenz A-
specific precursors prevaccination, and the precursor frequency became detectable on day
14 or 56. A second pattern was a boost in which vaccine recipients had an increase in the
number of IFN -y secreting cells detectable on day 14 that remained high or increased
fuher by day 56. We also observed that some donors had a short-
term boost where the
precursors increased at day 14 but went back to pre-
vacci levels by day 56. Aliquots of
PBMC from all three time points were used in the same assay; therefore, any increases in
IFN-y secretion were due to increases in the number ofT cells with 
influenz A
specificity and not due to varation between 
assays. The viruses used in the ELISPOT
assays were the same strains that were used in the vaccine, thus 
makng it possible to
quatitate all of the possible responding cells.
To make sure that the IFN-y was secreted by CD8+ and CD4+ T cells, we used
two-color flow cytometr. Other groups have found that direct infection of T cells does
not induce significant IFN-y production (Sareneva et al.
, 1998). It has previously been
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shown in vitro 
that PBMC stimulated with influenz virus 
produce IPN-y (Yamada et aI.,
1986). IFN-y gene expression is controlled at the level of transcription
, and IL- 18 (IFN-
inducing factor) can induce IFN-y production in human PBMC (Ushio et aI., 1996).
The results of our intracellular IFN-
y staining determined that mostly CD8+ T cells
secrete IFN-y, some CD4+ T cells secrete IFN-
y, while very few CD56+ NK cells secrete
IFN-y. LCMV infection of mice was also reported 
to induce IFN-y secretion by CD8+ T
cells , some CD4+ T cells, and very fewNK cells (Nguyen and Biron, 1999). In our
system, the IFN-y productio was the same whether the stimulator PBMC were infected
with live virus and then irradiated and added as APCs to the ELISPOT assay, or the live
virus alone was added to the PBMC in the ELISPOT assay. 
Furhermore, the infected,
irradiated PBMC alone did not secrete any IPN-
y. All of these results indicate that the
IFN-y secretion is due to a specific interaction between the T cells and infected APCs.
Evidence that the responses were specific is also shown by the lack of detectable IFN-
productio by the PBMC of several of the donors at day 0 and sometimes at day 14. In
other studies we have also observed donors without 
infuenza specific memory T cells
using ths assay, indicating that the virus infection alone does not nonspecifically activate
IFN-y secretion.
Quatitating the changes in 
the numbers of CTL that recognize epitopes on
viruses or other pathogens is importt in assessing vaccine immunogenicity. Our results
with bulk cultue cytotoxicity can thus be verified using the ELlSPOT assay to measure
changes in CTL responses to vaccines and determine the effectiveness of a vaccine in
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boosting the number of CTL. Using the ELISPOT assay it is possibl
to be more
quantitati because CTL activation is detected at the single cell level. To our
knowledge this is the first human vaccination study to use the IFN-
y ELISPOT to
measure changes in T -lymphocyte responses. One group used the ELISPOT assay to
measure changes in CTLp frequency in the mouse to a multi-epitope vaccine for HIV and
Plasmodiumfalciparum 
(Hane et aI., 1998), but only peptide-stimulation was used in
the assay. In the past, the LDA has been used to measure changes in the 
CTLp
frequency, but several groupS have found this assay to underestimate the actual number
ofCTLp (Lalvan et aI., 1997; Murali-Krshna et aI., 
1998; Larsson et aI., 1999).
The results of the chromium release and the ELISPOT assays showed similar
findings; however, when a discrepancy occurred, usually an increase in IFN-
y secreting
cells was detected in the ELISPOT assay but not in the chromium release assay. Perhaps
the stimulation time involved in bulk cultue cytotoxic T cell analysis makes it 
more
diffcult for all virus-specific cells to 
remain viable. Thus, some CTL killng may 
have
been observed on another day post-stimulation; we only tested at the day 7 time point. 
wil be importt to confrm and extend observations comparing the chromium release
assays and IFN-y ELISPOT assays in 
futue vaccine studies. We can not directly confirm
that the IFN-y secreting cells are the cytotoxic cells detected by the chromium release
assay, but often when there was an increase in cytotoxicity post-vaccination there was
usually an increase in the frequency ofIFN-
y secreting cells and the majority ofIFN-
secreting cells are CD8+. Furermore, the 
CTL epitopes on infuenz proteins that were
previously described all induce IFN-
y secretion by PBMC pulsed with peptide.
. Y;'
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Developing an infuenza vaccine that can protect humans against antigenic ally
varant viruses of varous subtypes will require more than the induction of neutralizing
antibodies. These techniques may be useful in determining whether the newer cold-
adapted influenza vaccines (Belshe et aI., 1998) can boost CTL responses. Inducing and
augmenting cross-reactive T cells that recognize and kil cells infected 
with variant
infuenza A viruses may provide this cross-subtype protection (Fig. VII- I). This Flu-
Iscom vaccine has been shown to activate T cells in mice (Morein et aI. , 1984; Takahashi
et aI. , 1990; Sambhara et aI. , 1998) and now in humans by stimulating CD8+ and CD4+
T lymphocytes. It is importt that such cross-reactive memory T cells can be increased
in number and able to perform anti-viral fuctions such as killng infected cells and
secreting IFN-y when vaccinated individuals become exposed to infuenza viruses with
variation in the surface glycoproteins (Fig. VII - 1).
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Fig. VII-I. Potential Role ofFlu-Iscoms: Increasing Numbers ofIFN-
Secreting T Cells Respond to Influenza Infection by a Novel Subtype.
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D. THE ROLE OF 
y/'6 T CELLS IN INFLUENZA A VIRUS INFECTION IN
HUMANS.
The role of y'6 Tcells in virus infection has not been well defined. Since the ligand for
the TCR has not been deciphered, little is known about what these T cells recognize. We
have shown that there is a population ofy'6 T cells in human PBMC that can secrete IFN-
y and upregulate activation markers in response to influenz A virus 
infection. The y'6 T
cell activation was characterized using the PBMC of several donors. Although there
were differences in y'6 T cell number and the extent of activation
, there were clear
increases in activated y'6 T cells in the infuenz-infected PBMC of all donors tested.
The role of y'6 T cells in defense from infuenza virus infection has been analyzed
in the mouse model. When a component of the mycobacterium cell wall (TDM) is
administered Lv. to normal mice, they acquire resistace to lethal 
infuenz infection
(Ln.) (Hoq et al. , 1997). These mice were depleted of y'6 T cells with a monoclonal
antibody, and the resistace was lost (Hoq et aI. , 1997). Recently, these findings were
validated when TCR '6-/- mice given TDM were found to have insufficient 
resistace to
infuenz infection (Hoq et aI. , 1999). These results suggest that y'6 T cells can 
playa
role in protection against infuenz A virus infection. Furermore
, y'6 T cells were
shown to increase in the BAL late in inection, generally after 
the virus is cleared
(Carding et al. , 1990). TCR usage by the "('6 T cells is first by Vy4, and then later by a
Vy2Ny1 population (Carding et aI., 1990). The "('6 T cells recovered durg infuenz
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infection are activated and transcribe many cytokines (Eichelberger et aI., 1991). This
supports our finding that there is a population ofy'6 T cells in human PBMC that can
produce IFN-y and upregulate activation markers in response to influenza virus infection.
Although we could not completely elucidate the mechanism 
utilzed by these y'6 T
cells to become activated by influenz A virus
, we did rule out several possibilties. 
inactivated the virus by boiling and observed that the cytokine secretion and CD25
upregulatio substatially decreased. This suggests that 
either the virus infection is
importt or the boilng process destroys the recognition of 
a viral protein. The infection
may either induce cytokines/factors that activate the 
y'6 T cells or allow entry into the
class I presentati pathway (Fig. VII-2). Since the activation of 
CD8- y'6 cells was not
blocked with an anti-class I antibody, we determined that the 
y'6 T cells probably do not
need interaction with the class I molecule to become activated. The specificity of 
y'6 T
cells remains il-defined, since recognition has been demonstrated to classical and non
classical MHC, MHC-like molecules, heat shock proteins, viral glycoprotei
, and non
peptidic mycobacterial antigens (Bluestone et ai., 1995; Dieli et ai.
, 1997; Sciamas and
Bluestone, 1998).
If the virus inection itself induces the secretion of a molecule that is recognized
by y'6 T cells, it is importt to determine whether any virus can have this effect. We
infected the PBMC of donor 1 with another virus, vaccinia virus; however
, there was no
activation of the CD8- y'6 T cells. Ths is in contrast to findings in a human clone where
vaccinia virus infected tagets were lysed by y'6 T cell clones. 
Since there seem to be
1;'
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varous populations ofy'6 T cells in humans (natual kiler inhibitory receptor + or-
cytokine + or - , and cytotoxic + or -), perhaps we are analyzing a different population of
y'6 T cells than the vaccinia virus-specific y'6 T cell clones previously reported. In our
laboratory it has been shown by Anuja Mathew that there is an increase in the number of
y'6 T cells in bulk cultue when stimulated with dengue virus (unpublished data). It is
possible that there are certain viruses that can induce y'6 T cells while others canot.
Several groups have suggested that y'6 T cells recognize heat-shock proteins (HSP 65
HSP 60) secreted by the injured cells; however, the role of heat-shock proteins is not
clear. Some speculate that they are superantigens, while others suggest that they may
present antigen to the y'6 cells. y'6 T cells can also be activated by certn cytokines, such
as IL- 12 with TNF-a (Ueta et aI. , 1996).
For y'6 T cells to promote recovery from infection with novel influenza virus
strains , they need to be cross-reactive between infuenza virus strains and subtypes.
Whether this response would be cross-reactive memory to the virus or a more nonspecific
response to factors from infected cells, we were not able to distinguish. However, we
tested additional inuenz virus strains/subtypes to look for stimulation of the y'6+CD8-
T cells in the PBMC. The AlJapan305/57 (H2N2) strain stimulated 1 % more y'6+CD8-
T cells than the PR/8/34 (HINI) virus (approx. 5% to 4% ofy'6 T cells respectively).
However, the Alort Chalmers/I/73 (H3N2) virus did not stimulate IFN-y production by
y'6 T cells , even though the CD8+ population as a whole did respond to ths virus (approx.
1 % of all CD8+). Different results were observed by Ponniah et al. using mouse y'6 T cell
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hybridomas that were stimulated to secrete IL-2 in response to X-31 (H3N2), PR/8/34
(HIN1), and B/HK/8/73 (influenz B) viruses (Ponniah et aI. , 1996). These results are
somewhat conficting with our findings, since they observed a response to an influenza
H3N2 subtype virus while we did not. One hypothesis is that the infectivity ofthe virus
is important to activate the y'6 T cells , which may explain the results by Ponnah et al. and
the results by our laboratory if the Alort Chalmers/l/73 (H3N2) virus is not very
infectious. Another possibilty is that the viral proteins bind directly to the y'6 TCR for
stimulation. Ths has been shown with HSV- l y'6 clones that recognize the N-terminus of
the surace glycoprotein (Sciamas and Bluestone, 1998). In our case, since the H3 and
HI molecules are very diverse, this would explain the loss of recognition we observe , but
it would not explain the results by Ponniah et al. since they had recognition to all
influenz subtypes (even type B).
Heterotypic immunty specific for infuenza A viruses promotes clearance of
antigenically distinct strains and subtypes of virus. It would be beneficial to have y'6 T
cells with heterotypic immunty, since y'6 T cells can reside or localize to the site of
infection, lyse infected cells, and secrete cytokines. Increases in y'6 T cells have been
detected in the BAL up to 5 days earlier upon secondar infuenz virus infection
(Carding et aI. , 1990), suggesting either a memory population ofy'6 T cells exists or a
rapid secretion of chemokines by ap memory T cells localizes y'6 T cells to the site.
Whether y'6 T cells are activated by a direct signal, or an indirect signal (Fig. VII-2) they
may help decrease virus titers by secreting IFN-y, killng virus-infected cells, or
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promoting tissue regeneration. Our results support the hypothesis that 
y'6 T cells can
respond to infuenza A virus infection in a non-MHC class I restricted fashion
, which
may help promote a more rapid recovery.
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Fig. VII-2. Models for y'O T Cell Activation.
1. Virus Infection Induces a Secreted Factor that Directly Activates y'6 T Cells:
actororcytokine 
p. 
ecreted 
"- 
Virus B, Mcp, Mo, DC, etc. IFN-
2. Virus Infection Induces a Secreted Facter that Indirectly Activates y'6 T Cells:
Virus Class I
Presentation
T Cell
Activation
IFN- y'O . IL-
Activatio
y'6 cell
3. Viral Protein is Recognized, but Does Not Bind After Boiling of Virus:
i)i)
i)\i) 
Infects Cell, Replicates
IFN-
Virus Viral Protein Binds TCR
4. Viral Peptides are Presented by MHC Molecules to Activate y'6 T Cells:
IFN -
Virus Infects Cell, Class I Pathway, Activates y'6 T Cell
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E. CONCLUSIONS.
The results in this thesis examine the T -lymphocyte responses to influenza virus infection
and vaccine administration. The major conclusions of this thesis are:
1. Humans have a broad multi specific memory T cell. 
response specific for
infuenz A. Responses to 7 of the 10 viral proteins were detected in the PBMC of donor
1, indicating that recognition of a varety of epitopes occurs 
in humans. This is unlike the
T cell response observed in mouse models where very limited numbers of
immunodominant epitopes were present. Both CD4+ and CD8+ T cell responses were
detected in all donors.
2. There are T cells in normal adult donors that recognize autologous cells
infected with human, swine and avian strains of influenza viruses. These responses were
detected at the clonal level and the bulk cultue level. 
Nonconservative mutations in
epitopes from avian and swine strains resulted in a loss of recognition by T cells.
3. The increases in specific lysis previously detected in volunteers vaccinated
with Flu-Iscom and Flu-Iscomatrx vaccines were due to an 
increase in the number of
infuenz-specific CTL post-vaccination. These increases were not detected in 
volunteers
who received the Fluzone control vaccine. Increases in the number of 
infuenza peptide-
specific CTL were also detected post-vaccinati
4. Humans have CD8- y'6 T cells in their PBMC which can secrete IFN-
y in
response to live infuenz A virus infection in vitro. The CD8- 
y'6 T cells upregulate
CD69 and CD25 in response to the virus infection. 
Ths response was not blocked by
anti-class I monoclonal antibodies and does not occur after vaccinia virus infection.
':(.
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This thesis analyzes the human T cell response to influenz virus infection
, furthering our
understanding of how the immune system responds to viruses. Although the mechanisms
of ap and y'6 T cell activation are not fully uncovered, we now understand that they are
activated in response to influenz infection in humans which may provide a second line
of defense from varant influenza strains.
- . -,---- --. -'-
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